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 Injuries to the craniofacial skeleton have a tremendous economical and social impact on 
our healthcare system and society. Presently, clinical management of craniofacial trauma 
remains highly challenging and various efforts have been undertaken to develop and improve 
existing therapies for craniofacial reconstruction. Among these efforts, mounting evidence has 
demonstrated that inflammation is among the first events to determine fracture healing outcome. 
Thus, understanding how inflammation affects bone healing and subsequently modulating 
inflammation to enhance bone regeneration has become a promising strategy. Toll-like receptor 
4 (TLR4) is a member of TLR family that is central to inflammation by virtue of its involvement 
in host defense for microbial infection as well as tissue regeneration. As such, TLR4 is a 
potential candidate for investigation and subsequent immune modulation. This work utilized 
various knockout (KO) mouse models for TLR4 and its associated inflammatory mediators as 
tools to study the role of inflammation in calvarial bone healing in the absence or presence of 
bone grafts. In the absence of bone graft, a similar accelerated phenotype was observed between 
MyD88 KO mice and DC-TLR4 KO (TLR4 depleted in dendritic cells) mice, indicating that 
dendritic cell expression of TLR4-mediated MyD88 signaling was detrimental for calvarial bone 
healing. In addition, TLR4 depletion in myeloid cells also resulted in accelerated bone healing 
via enhanced osteoclastogenesis within a calvarial defect model. However, in the presence of 
bone graft, inhibited bone healing and decreased osteoclast-mediated graft remodeling was 
observed in TLR4
 
KO mice or when TLR4 signaling was locally inhibited, establishing an 
                TLR4-MEDIATED CALVARIAL BONE REPAIR: 
                             INVESTIGATING ITS ROLE AND POTENTIAL USE  
                                          FOR REGENERATIVE MEDICINE  
                                                              Dan Wang, Ph.D 
University of Pittsburgh, 2015
 
 v 
important and novel role of TLR4 in graft-based bone repair. Taken together, these data 
demonstrate that TLR4 signaling and its pathway mediators play an important regulatory role in 
osteoclastogenesis, highlighting a potential opportunity in which appropriate modulation of 
TLR4 signaling can be used to initiate early healing in bone defects or assist in bone graft-
mediated therapy to improve clinical outcomes. 
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1.0  INTRODUCTION: NOT ALL BONES ARE EQUIVALENT: COMPARISON OF LONE 
BONE VERSUS CALVARIAL BONE DEVELOPMENT, STRUCTURE AND HEALING  
Craniofacial defects resulting from trauma, surgery, or congenital disorders are notoriously 
difficult to repair and present a significant burden to the healthcare system. Within the United 
States, approximately 2 million head injuries are reported annually with an estimated 592,000 
cranial surgeries performed in 2006 alone 
1-4
. While it is often assumed that regenerative 
therapies developed to correct defects within the appendicular skeleton will translate for 
application in craniofacial reconstruction, this is not a fully accurate assumption as there are 
fundamental differences in the developmental biology and anatomy of the craniofacial and 
appendicular skeleton. For example, long bones develop via endochondral ossification and 
require a cartilaginous intermediate whereas most calvarial bones are formed through 
intramembranous ossification. Moreover, the craniofacial complex includes a number of unique 
tissues (dura mater, periocranium, suture, and central nervous system), which can have a critical 
impact on the fracture repair process and regenerative capabilities of calvarial bone. Thus, our 
current understanding regarding the well-studied microenvironment of long bone fracture repair 
and their corresponding therapeutic treatment options might not be entirely applicable or 
appropriate for calvarial bone. Here we present and discuss aspects of development, structure, 
and repair processes which form a basis for distinction between calvarial bone and long bone. 
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Understanding the unique properties of calvarial bone and its healing process is essential for the 
development of tailored therapeutic strategies for skull bone repair 
5-7
. 
1.1 THE DEVELOPMENTAL BIOLOGY OF CALVARIAL BONE 
The developmental biology of calvarial bone formation is distinguished from that of long bone 
formation by virtue of several criteria, including: 1) the embryonic origins of the tissues; 2) the 
modes of ossification, and; 3) the signaling molecules which govern tissue formation of calvarial 
bone and long bone may also have differential effects on tissue remodeling and repair.   
1.1.1 The Embryonic Origins and Modes of Ossification 
Calvarial bone and long bone are composed of cells with different embryonic origins, which 
have implications on their ability to repair bone. Cells of long bone are derived from lateral plate 
mesoderm, whereas cells of calvarial region are derived from neural crest and cephalic 
mesoderm 
8,9
. The lateral plate mesoderm and neural crest in turn, are derived from mesoderm 
and ectoderm germ layers, respectively. Initially, the discovery that bone could be derived from 
two distinct germ layers was surprising as it contradicted classical germ-layer theory which 
stated that a specific tissue could be only derived from a particular germ layer. For example, 
muscle, mesenchyme, connective and vascular tissues were formed from mesoderm whereas 
nerves and epidermis were formed from ectoderm 
10
. 
The differential embryonic origins of bone tissues and distinct ossification modes may 
impact the ability to repair bones of the calvarial and axial skeletal systems 
11
. Skeletal defects 
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were created in the mandible (neural crest-derived bone) and tibia (mesoderm-derived bone), and 
neural crest-derivatives and non-neural crest-derivatives were labeled with GFP and β-
galactosidase separately 
12
. It was observed that GFP-expressing neural crest-derived skeletal 
progenitors repaired neural crest-derived mandible and β-galactosidase expressing mesoderm-
derived skeletal progenitors repaired the tibia, indicating that there are two separate pools of 
skeletal progenitor cells that exclusively repair bone according to their embryonic origins 
12
. To 
determine the functional interchangeability of these two pools of skeletal progenitor cells, 
grafting experiments were performed. Mesoderm-derived skeletal progenitors could not 
differentiate into osteoblasts after they were transplanted into mandible defects, but neural-
derived skeletal progenitors could differentiate into osteoblasts after they were transplanted into 
tibia 
12
. Expression of an important developmental gene, hoxa11 has been linked to the 
aforementioned plasticity of neural crest-derived skeletal progenitors 
12
. Furthermore, bone 
progenitors cells from different embryonic origins also exhibit differences in proliferation and 
osteogenic potential, which translate into more robust bone regeneration. It suggests that the 
unique characteristics of bone cells from different embryonic origins might have an influence on 
bone repair.  However, the above study does not take into account the potentially confounding 
effects of cell heterogeneity within their mesoderm- and neural crest-derived cell populations. 
For example, a recent study reported that a single type of mesoderm-derived skeletal progenitor 
found in the growth plate of long bone gave rise to at least 8 subpopulations, each with different 
propensities to form bone, cartilage and stromal cells 
13
. As such, even though it appears that 
embryonic origins may differentially influence the ability of neural crest- and mesoderm-derived 
skeletal progenitors to repair calvarial and axial skeletal systems, further study is warranted. 
Despite of their distinct developmental origins, calvarial bones and long bones both 
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develop from mesenchymal condensations but ultimately form through distinct modes of 
ossification. During mesenchymal condensation, mesoderm- and neural-crest derived 
mesenchymal cells halt their proliferation and form a cluster that is devoid of blood vessels, prior 
to undergoing stepwise differentiation into skeletal cells 
14
. Calvarial bones are primarily formed 
through intramembranous ossification, although a small subset, including the temporal, occipital, 
sphenoid, and ethmoid bones, form through a combination of endochondral and 
intramembranous ossification. During intramembranous ossification, osteoblasts directly 
differentiate from the pre-osteogenic mesenchymal condensates and secrete bone extracellular 
matrix to form the ossification center. Subsequently, the osteoblasts continue to differentiate, 
followed by vascularization and bone marrow formation. In contrast, long bone development 
proceeds by means of endochondral ossification instead, which requires a cartilaginous template 
to be formed prior to bone conversion. The endochondral process is characterized by 
differentiation of mesenchymal stem cells (MSCs) into perichondrial cells and chondroblasts, 
which are located at the periphery and center of mesenchymal condensates, respectively 
14
, Upon 
differentiation into chondroblasts, cells resume proliferation to promote longitudinal bone 
growth, eventually becoming hypertrophic chondrocytes that secrete mineralized cartilage 
matrix. This results in a primary ossification center in the bone diaphysis and secondary 
ossification centers in the bone epiphyses. With subsequent vascularization, osteoblasts and 
osteoclasts are recruited to resorb the hypertrophic chondrocytes and replace the mineralized 
cartilage with new bone 
15,16
. Thus, calvarial bones and long bones are formed initially from 
mesenchymal condensations but subsequently utilize intramembranous and endochondral modes 
of bone ossification, respectively.  
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1.1.2 Similarities and Differences in Signaling Molecules  
Considerable similarity and differences exist in the signaling pathways and gene expression 
patterns during calvarial and long bone development. As described earlier, both types of bone 
form mesenchymal condensations prior to undergoing endochondral or intramembranous 
ossification 
17
. Therefore, it is not surprising that the mesenchymal condensation of both 
calvarial and long bones involve similar signaling pathways and molecular actors including 
members of the Transforming Growth Factor-Beta (TGF-β), Bone Morphogenetic Protein 
(BMP) and Fibroblast Growth Factor (FGF) families, transcription factors including Sox9 and 
adhesion molecules including cadherins and neural cell adhesion molecule 
14
. During the 
subsequent endochondral or intramembranous ossification, bone- and cartilage-encoding genes 
are utilized to different extents. Chondrocyte-independent, intramembranous bone formation 
predominantly utilizes predominantly bone-encoding genes, whereas chondrocyte-dependent, 
endochondral bone formation utilizes a mix of cartilage- and bone-encoding genes. Bone-
encoding genes include collagen type 1 (col1a1), bmp2 and bmp6, whereas cartilage-encoding 
genes include sox5, sox6, sox9, indian hedgehog (ihh), collagen type 2 (col2a1) and collagen 
type 10 (col10a1) 
18-20
. For example, the bone-encoding gene COL1A1 forms a major component 
of bone extracellular matrix that is eventually deposited with hydroxyapatite crystals, producing 
a calcified matrix that is stiff and resistant to fracture 
21
 whereas the cartilage-encoding gene 
COL2A1 forms a major component of cartilage extracellular matrix and deletions to this gene 
leads to cartilage and skeletal abnormalities 
22
. However, some genes including runx2 are 
utilized to form both bone and cartilage and thus do not fit neatly into the above classification 
scheme 
23,24
. Despite these exceptions, the differential use of bone- and cartilage-encoding genes 
by endochondral and intramembranous ossification can affect calvarial and long bone formation 
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in distinct manners. For example, as a cartilage-encoding gene, IHH is a vital growth factor that 
regulates the proliferation and differentiation of chondrocytes 
11,25,26
. Knockout mice lacking ihh 
(ihh
-/-
) exhibit severe defects in endochondral bone formation with limbs that are severely 
reduced in size 
11,25,26
. In contrast, intramembranous bone formation in ihh
-/-
 mice was less 
affected and mature osteoblasts that expressed osteocalcin were observed in parietal bone 
11,25,26
. 
Also, high mobility group box 1 (HMGB1) is another gene which differentially affects 
endochondral bone formation and intramembranous bone formation. HMGB1 is found in 
chromatin protein and is involved in inflammation and tissue regeneration. HMGB1 also acts as 
chemotactic agent to osseous cells during endochondral ossification. Recombinant HMGB1 
(rHMGB1) stabilized the RANKL/OPG expression ratio and augmented the expression of TNF-
 and IL-6 in long bone-derived cell cultures, but not in calvarial bone-derived cell cultures, 
suggesting that intramembranous and endochondral-derived osteoblasts exhibit a different 
response towards HMGB1 
27
. This result is further supported by observations that endochondral 
ossification, but not intramembranous ossification, was significantly impaired in embryonic 
HMGB1 knockout mice 
28
.  
Thus, as a result of their distinct developmental origins and modes of bone formation, 
calvarial and long bone skeletal cells utilize different molecular mechanisms to form mineralized 
bone. Understanding the subtle differences between these molecular pathways will have 
important implications for identifying the most effective therapies for cranial bone repair. 
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1.2 STRUCTURAL DIFFERENCES BETWEEN CALVARIAL BONE AND LONG 
BONE 
The craniofacial skeleton protects the brain and supports the structures of the face, whereas the 
appendicular skeleton protects the internal organs, provides structural support and contour to the 
body, and interacts with muscle and soft tissues to permit locomotion and movement. The unique 
organs, such as dura mater, periosteum and suture, and bone marrow directly influence fracture 
healing within the craniofacial skeletal system. 
1.2.1 Dura Mater 
The dura mater is a fibrous membrane that surrounds the intracranial and spinal nerve structures. 
It not only acts as a barrier to protect the central nervous system from traumatic injuries and 
infection, but is also essential for tissue regeneration. The dura mater has five layers (the bone 
surface, external median, vascular, internal median, and arachnoid layers) with varying 
thicknesses, orientations and structures 
29
. Functionally, the dura mater is a unique and important 
source of multipotent mesenchymal cells, whereas bone marrow and periosteum are the most 
significant sources of osteoprogenitors during long bone formation and remodeling. The dura 
mater provides paracrine signals which are essential for calvarial defect healing 
30
. Dura mater 
stem cells also showed greater osteogenic differentiation and enhanced matrix synthesis 
compared to bone marrow stem cells on biodegradable polylactic-co-glycolic acid (PLGA) and 
tissue culture plastic 
31
. This may partially explain the function of dura mater and its resident 
cells in calvarial bone healing and its roles as being promising candidates for cranial bone tissue 
engineering 
32
. 
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The osteogenic function of dura mater is observed to vary with age. Genome-wide 
expression analysis showed that juvenile and adult dura mater have different gene expression 
profiles after rat calvarial fractures. Juvenile dura mater cells expressed more osteogenic and 
osteoclastogenic differentiation markers than adult dura mater cells 
33
. This stark difference in 
the osteogenic properties of dura mater has been demonstrated in several animal studies where 
transplantation of juvenile dura into an adult rat resulted in heterotopic membranous ossification 
34
 whereas transplantation of mature and immature dura mater into calvarial defects of immature 
animals resulted in reduced and successful bone repair, respectively 
35
. Although the precise 
factors responsible for the differences in regenerative capabilities of immature and mature dura 
mater are unknown, this difference may partially be due to the impact of mechanical strain on the 
juvenile dura mater which results from skull growth and expansion. Indeed, clinical observations 
suggest that calvarial defect healing is most efficient during the period of active intracranial 
volume expansion, which usually refers to the first two years of life 
36-38
. It is possible that the 
differences in bone healing capacities between children younger and older than two years of age 
might be partially due to the differences in underlying dura mater function during its 
developmental processes.  
1.2.2 Periosteum 
The periosteum induces osteogenesis during endochondral ossification, making it an 
indispensable player during cartilage repair and long bone fracture healing 
39
. The periosteum 
consists of an outer fibrous layer containing mainly fibroblasts and an inner cambium layer 
containing nerves, capillaries, osteoblast lineage cells, and undifferentiated cells 
40
. 
Mesenchymal stem cells (MSCs) residing inside the periosteum and bone marrow exhibit 
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comparable growth kinetics and colony-forming potential 
41
. An in vitro study demonstrated that 
upon stimulation with BMP-2 and FGF-2, periosteal cells and bone marrow-derived stromal cells 
both differentiated into osteoblasts but periosteal cells proliferated faster whereas bone marrow 
cells were more osteogenic 
42
. The periosteum is also a major source of chondrocytes and 
osteoblasts during callus formation, underscoring its importance in endochondral bone repair. 
Loss or damage to the periosteum has been observed to result in delayed long bone healing or 
nonunion 
43
.  
The periosteum has potential applications in long bone tissue engineering 
44,45
. 
Composites of periosteal MSCs and hydroxyapatite ceramics induced bone formation when 
subcutaneously implanted into syngeneic rats 
46
.  Periosteum has also been described as essential 
for allograft performance. Tissue-engineered periosteum used in combination with allograft is 
superior to allograft alone in femoral defect reconstructions 
47
. Artificial periosteum along with 
incorporated osteogenic-differentiated bone marrow stem cells also showed enhanced 
osteogenesis 
48,49
. Age seems to influence the osteogenic potential of periosteum which is similar 
to dura mater. It is suggested that juvenile periosteum is more capable of bone regeneration than 
adult periosteum in a rabbit parietal defect model 
50
. 
Although periosteum is essential in long bone fracture healing, studies suggest that its 
role in calvarial defect healing may be less crucial when compared to dura mater. A 
comprehensive study was performed to histologically assess the contributions of periosteum, 
cortical bone, endosteum, bone marrow and dura mater in rabbit tibial and calvarial bone healing 
51
. After creating 10.8 x 4.45 mm tibial or calvarial cortical defects, Teflon cups and films were 
inserted into the defects in various orientations and positions for 10 – 12 weeks, in order to 
isolate and prevent specific tissues from participating in bone healing 
51
. For example, placement 
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of the Teflon cup with its orifice/opening facing out towards the periosteum allowed for studying 
the effects of periosteum-mediated bone healing whereas placement of the Teflon cup with its 
orifice/opening facing the opposite direction allowed for studying the effects of endosteal- and 
medullary bone-mediated healing 
51
. For tibial bone healing, periosteum was found to play a 
major role in bone repair whereas cortical bone, endosteum and bone marrow played a less 
prominent role 
51
. For calvarial bone healing, dura mater produced more bone formation than 
cranial periosteum but both periosteal and dura mater were required for complete bony 
restoration 
51
. Similar results were obtained when bone grafts were implanted into 90 mm
2
 rabbit 
calvarial defects for 10 weeks 
52
. Silastic barriers were used to cover the dura mater, cranial 
periosteum or both dural mater and cranial periosteum to isolate the contributions of various 
tissues to bone graft-mediated healing, which was assessed using fluorescein labeling 
52
. Dura 
mater was found to improve bone formation throughout the entire graft, whereas periosteum only 
enhanced bone formation on the periosteal surface of the bone graft 
52
. While both periosteum 
and dura mater showed osteogenic potential, this result suggests that the dura mater is 
predominantly responsible for the healing outcome in calvarial repair 
52
. In addition, autogenous 
periosteal cells when used in combination with a bovine inorganic apatite and collagen-based 
biomaterial did not improve bone formation in a rat calvarial defect model when compared to 
biomaterial alone 
53
. Thus, while both dura mater and periosteum show potential for enhancing 
bone graft repair, further study including cell lineage tracing as well as characterization of the 
proliferative and osteogenic capabilities of skeletal progenitor cells within these tissues will 
further delineate their contributions to bone repair and explain why dura mater might be more 
effective for calvarial bone repair.  
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1.2.3 Sutures 
The cranial suture is a fibrous joint-like organ present in calvarial bone only. Six primary sutures 
exist which contribute to the growth, healing and elasticity of the skull. The suture is first formed 
as a thin layer of undifferentiated tissue between two bones, and later presents a serrated pattern 
after birth 
54,55
. It allows the necessary expansion during brain growth, slightly movements of 
cavlarial bones and absorption of mechanical forces to protect the underneath central nervous 
system. Abnormal sutures growth largely influence the development of calvarial bone and brain, 
like the formation of craniosynostosis due to the prematurely ossification of sutures. Differential 
gene expression profiles have been implicated in fused and patent sutures 
56
. Besides its role 
aforementioned, suture also serves as an intramembranous bone growth site. The roles of suture 
resident cells or suture expressing transcription factors and growth factors on bone development 
and regeneration have been implicated 
57
. Some of suture-expression osteogenic factors, such as 
Runx2, Nel-like molecule-1 (Nell-1), TGF-β1, FGF2, have been observed to play a role in 
premature fusion of calvarial suture 
58-61
. Vice versa, players associated with craniosynostosis 
have also been studied to understand their potential capacity in bone healing. For example, Nell-
1 is a secreted protein identified from premature fused sutures. Along with demineralized bone 
matrix carrier, Nell-1 is found to improve bone healing in a critical-sized femoral segmental 
defect in rats 
62
. Twist1 which is associated with premature synostosis of cranial sutures in both 
mice and human, has been suggested to inhibit osteoblast differentiation in vitro 
63,64
 and cause 
reduced bone formation in vivo 
65
. Thus, molecules and cells identified in premature fusion of 
sutures might be potential candidates to assist bone repair. 
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1.2.4 Bone Marrow 
Besides differences between dura mater, periosteum and sutures, long bone and calvarial bone 
differ in terms of bone marrow amount. Long bones, by virtue of their larger bone volume and 
elongated structure contain a well-defined marrow cavity that serves as the major site for 
hematopoiesis whereas calvarial bones by virtue of their smaller and flatter structure do not 
contain much bone marrow. The close association of marrow tissue with skeletal tissue may play 
a pivotal role in regulating each other’s activities.  For example, ectopic subcutaneous 
transplantation of marrow tissue in rats result in functional marrow tissue encased in a shell of 
bone 
66
 whereas ectopic bone formation in subcutaneous and intramuscular sites often results in 
the formation of an accompanying marrow cavity 
67
. While ectopic bone in the renal capsule but 
do so without any bone marrow formation 
68,69
. In contrast, calvarial tissues do not exhibit this 
close association as transplantation of mouse fetal calvarial-derived skeletal cells to the renal 
capsule forms ectopic bone but without any accompanying bone marrow 
68,69
. Likely candidates 
that may be responsible for this marrow and skeletal tissue association include cell-to-cell 
interactions between long bone-derived skeletal cells and marrow-derived hematopoetic stem 
cells (HSCs). These cells reside together in locations known as stem cell niches where the 
immediate microenvironment consists of various biochemical, neuronal, mechanical cues which 
arise as a result of cell-to-cell and cell-to-matrix interactions, allowing stem cells to self-renew as 
well as respond to external stimuli such as injury 
70
. For example, osteoblasts 
71
 and 
mesenchymal stromal cells 
72
 are known to regulate HSC numbers and self-renewal, 
respectively.  However, the effect that HSCs may have on skeletal cells along with their net 
effect on bone healing is uncertain. Studying the nature of these interactions as well as the 
potential impact on fracture healing is an interesting concept that warrants further study.  
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Calvarial bones and long bones are surrounded by different structures including dura 
mater, periosteum, sutures and bone marrow, each of which has a profound impact on the 
proliferation and differentiation of bone cells as a result of cell-to-cell interactions including 
paracrine signaling. Understanding the effects of these interactions on calvarial bone formation 
and repair will be helpful for personalizing therapies based on the anatomical location where an 
injury is sustained.  
1.3 AN OVERVIEW OF FRACTURE REPAIR IN CALVARIAL BONE AND LONG 
BONE 
The developmental and structural differences between calvarial bones and long bones as discussed in 
preceding sections directly influence their biological healing process after fracture. Fracture repair is 
a coordinated response that consists of the pathways involved in normal embryonic development 
as well as the participation of bone cells, immune cells, extracellular matrix, etc 
73
. Based on 
histological observations in both patients and animal models, the endochondral bone fracture 
healing process is usually divided into four stages: inflammation, soft callus formation, hard 
callus formation and bone remodeling stages 
74
. Although calvarial bone and long bone share 
similarities during fracture repair process, calvarial bone regeneration is still unique, such as it 
does not require a cartilaginous template and involvement of different surrounding tissue. We 
generally classify calvarial bone repair into inflammation, bone remodeling and bone formation 
stages for the following discussion. 
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1.3.1  The Inflammation Stage During Calvarial Bone and Long Bone Healing 
The inflammatory response after bone fracture shares similar events and signaling pathways with 
non-skeletal injuries. Despite the considerable controversies that exist regarding to the role of 
inflammation in fracture repair, it has received increasing attention not only for its role in host 
defense against infection but also in bone regeneration and repair 
75,76
. 
Hematoma formation and intense cell infiltration are the major features which are 
similarly observed during the first few days after calvarial fracture and long bone fracture. 
Inflammatory cells (platelets, macrophages, lymphocytes, monocytes, granulocytes) infiltrate the 
fracture hematoma, secreting cytokines and growth factors to initiate the healing cascade. 
Inflammatory cytokines such as IL-1, IL-6, and TNF-α that originate from macrophage and 
mesenchymal cells show increased levels right after fracture in both long bone and calvarial bone 
healing 
77,78
. These cytokines are highly involved in the inflammatory response and also play a 
role in promoting angiogenesis, recruiting fibrogenic cells to the fracture site and stimulating 
extracellular matrix synthesis. Similar to inflammatory cytokines, growth factors such as TGF-, 
PDGF, BMP-2, -4, -5, -6, and GDF-8 also show increased expression at this stage. These factors 
facilitate cellular (inflammatory cell and mesenchymal stem cell) invasion in a positive feedback 
loop, which is essential for initiating soft callus formation and controlling cellular proliferation. 
Differences also exist in the inflammatory stage between calvarial bone and long bone, 
such as dura mater reaction, hematoma property and gene expression profiles. A unique 
characteristic during the inflammatory phase of calvarial fracture healing is the early and 
essential involvement of the dura mater. An increase in dura mater cellularity is observed during 
this stage, which may be beneficial for healing response given that this tissue is a rich source of 
osteoprogenitors. Another unique part is the influence or consideration of hematoma during 
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fracture healing. Hematoma is critical for fracture healing and removal of fracture hematoma will 
lead to delayed healing 
79
. However surgeons are more cautious when treating hematoma occurs 
in traumatic head injury, the effect of hematoma in calvarial bone healing is still not yet clear 
80
. 
Furthermore, gene expression profiles also vary among injury sites and injured tissue types. For 
example, serum level of IL6 was higher and serum level of RANKL/OPG was lower in patients 
with a concomitant head injury and fracture compared to patients with fractures only (femur, 
clavicle, tibia). As differences in the expression profiles of RANKL, OPG, and IL-6 were 
observed, altered fracture repair outcome can occur between patients with these two different 
fractures 
81,82
. It suggests that in situation where a head trauma exists, the body prioritizes to 
protect the central nervous system from infection by eliciting a greater-than-normal 
inflammatory response, which may come at the expense of bone repair.  
 Various studies have explored the effect of modulating fracture-induced inflammation 
for obtaining desirable bone healing outcomes, including manipulating expression of 
inflammatory cytokine, chemokine, and growth factors (IL1, IL-6, IL-18, TNF-, Complement 
3, TGF-, VEGF, stromal cell-derived factor). However, the same inflammatory mediator might 
have different roles in regulating repair in calvarial bone and long bone. For example, Toll-like 
receptor4 (TLR4) is a member of transmembrane receptor family that activate the innate immune 
response by recognizing conserved molecular patterns of microbial products as well as 
endogenous ligands. TLR4 has been reported to have a profound role in mediating innate 
immune response and skeletal tissue homeostasis 
83
. We previously reported a rapid calvarial 
healing in TLR4
-/-
 mice histomorphometrically and radiographically, accompanied by an 
increase in dura mater cellularity and inflammatory cytokine expression at the early 
inflammatory stage 
78
. In contrast, a recent study showed that individuals with mutated TLR4 are 
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associated with long bone non-unions 
84
. However, this may be attributed to impaired 
recognition and elimination of pathogens in the wound site instead of innate differences between 
calvarial and long bone since sterile calvarial defects were employed. Thus, elucidating the role 
of inflammation in long bone and calvarial bone healing will be useful in determining whether 
immunomodulatory drugs may be used for bone repair.  
1.3.2 Bone Formation and Bone Remodeling Stages during Calvarial Bone and Long 
Bone Healing 
Bone formation stage during calvarial bone and long bone repair employ different cellular 
mechanisms that directly influence healing patterns. Chondrocytes and fibroblasts are the most 
active cell types during the soft callus formation phase of long bone fracture healing 
85
. 
Mesenchymal progenitors infiltrate the defect, differentiate into chondrocytes, and subsequently 
synthesize a cartilaginous matrix. This cartilage replaces the hematoma and forms a soft callus 
template in the soft callus formation stage. With mineralization of extracellular bone matrix, soft 
callus is gradually replaced by woven bone. During calvarial bone healing, osteoblasts and 
fibroblasts are the most active cell types during the bone formation stage. These osteoprogenitor 
cells can originate from multiple locations including the bone marrow, periosteum, dura mater 
and nearby soft tissue 
86
. Typical large, cubic, mononucleated osteoblasts are visible at the defect 
site as early as day 7 after calvarial fracture 
78
. The mineralized extracellular matrix is mainly 
secreted by mature osteoblasts. Woven bone matrix will mineralize and be gradually replaced by 
lamellar bone. Although calvarial bone and long bone ultilize different ossification modes, some 
similarity exists in the gene expression profiles during this stage. For example, the expression of 
inflammatory cytokines that are active during the inflammatory stage begins to decline during 
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the bone formation stage, while multiple growth factors including TGF-2, p3, GDF-5, and 
BMP-2, 3, 4, 5, and 6 show increased expression. Osteoblast, chondrocyte and fibroblast 
proliferation will be regulated by all the growth factors mentioned above. Angiogenic factors 
such as angiopoietins, VEGFs, BMPs, FGF-1, and TGF- stimulate vascular endothelial cells 
and trigger angiogenesis invasion into newly regenerated bone matrix 
87-89
. 
Bone remodeling stage starts with woven bone generating into cortical and/or trabecular 
bone configurations. Calvarial bone and long bone share similar histological healing patterns and 
gene expression profiles during this stage. This stage is characterized by the presence of 
osteoclasts, which leads to resorption of mineralized bone. Two main cytokines, M-CSF and 
RANKL (the ligand of NFB), are critical for the induction of bone resorption. M-CSF plays a 
role in the differentiation of osteoclast lineage cells from haematopoietic cells. RANKL is 
expressed by mature osteoblasts and is important in osteoclast differentiation 
90,91
. Inflammatory 
cytokines such as IL-1, IL-6, TNF-a, OPG, and RANKL that show increased expression during 
inflammation exhibit another peak in expression during bone remodeling, while members of the 
TGF-β superfamily display diminished expression. Regenerated lamellar bone will eventually re-
establish the geometric and functional properties of the fracture site. 
As mentioned, commonalities and distinct differences exist in terms of healing process 
between calvarial and long bone repair. Thus, careful consideration of these factors is necessary 
when design therapies for long bone and calvarial repair.  
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1.4 SUMMARY 
In summary, calvarial bone is a unique type of bone tissue that is distinct from long bone from 
various perspectives. In the course of its development, calvarial bone is formed mainly through 
intramembranous ossification and bypasses the cartilage intermediate stage observed in long 
bone formation. During fracture healing, a pronounced inflammatory response is elicited to favor 
protection of the central nervous system over bone repair. Structurally, dura mater and sutures 
are only found associated with craniofacial bone, which exert profound influences on healing 
outcome. These factors should be considered, allowing for the development of tailored 
treatments and interventions for either calvarial or long bone repair. 
Inflammation is an integral component of the response to injury and is increasingly 
recognized as playing an essential role not only in host defense against infection but also in 
tissue regeneration and repair 
75,76
. Traditionally, inflammation has often been negatively 
associated with pathological bone destruction. However, in recent years, there has been an 
increased interest in elucidating the positive role of inflammation in bone regeneration and 
repair. Furthermore, mounting evidences have also suggested that the initial inflammatory stage 
is among the first events to determine the fracture healing outcome 
90
. Toll-like receptor (TLR) is 
a receptor family, which plays a central role in the induction of sterile inflammatory cascades in 
response to tissue injury in many settings, including musculoskeletal trauma 
91
. The following 
studies utilized various TLR4-assocaited knock-out (KO) mouse models, as a tool 
92
 to 
understand the role of the innate immune system during  skull bone healing under clinically 
relevant settings. 
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2.0  ACCELERATED CALVARIAL HEALING IN MICE LACKING TOLL-LIKE 
RECEPTOR 4 
2.1 INTRODUCTION 
The skeletal and immune systems are interconnected and share multiple signaling pathways 
93
. 
The inflammatory stage of healing that occurs immediately after fracture is non-specific and 
shares signaling pathways with non-skeletal injuries like skin wound healing. Bone components 
exposed by long bone fracture possessed immunologic properties that play an important role in 
the induction of local, but not systemic, inflammation 
94,95
.
 
Inflammation promotes cell 
proliferation and migration into the fracture site, triggering a healing cascade within damaged 
bone 
85
.
 
Inflammation has a well-established role in promoting long bone regeneration. The use 
of nonsteroidal anti-inflammatory drugs is contra-indicated in patients with bone injuries 
96
.
 
Fracture repair is significantly delayed in COX-2
-/-
 mice, suggesting that efforts to blunt 
inflammation may be deleterious to fracture healing 
97
. However, other studies have observed 
accelerated fracture repair in the absence of an adaptive immune system 
98
. The role of the 
inflammatory response in bone regeneration is more complex than originally envisioned and is 
not fully understood. 
Toll-like receptors (TLRs) play an essential role in innate recognition of microbial 
products and are critical activators of the innate immune response. More than ten TLRs have 
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been shown to recognize distinct microbial products, such as microbial membrane lipids or 
nucleic acids. Another unique role of TLRs is to sense cellular stress or tissue damage by 
responding to endogenous ligands released from necrotic cells and damaged tissues 
99
.
 
Direct 
TLR signaling inhibits RANKL-mediated osteoclast differentiation, while TLR activation has 
also been shown to enhance osteoclast differentiation by inducing RANKL and TNF-α 
expression in osteoblasts 
100
.
 
Thus, the role of TLRs in bone healing remains unclear and 
deserves further investigation 
101-103
.  
Toll-like receptor 4 (TLR4), a cell surface TLR, plays a unique role in sensing tissue 
damage. TLR4 signaling is activated in response to tissue injury, resulting in the induction of a 
sterile inflammatory cascade 
83
.
 
TLR4 has also been implicated in regulating the systemic 
inflammatory response following bilateral femoral fracture 
104
. Whether TLR4 plays a role in the 
local inflammatory response to calvarial defects and the impacts of this response on healing 
remains unknown.  
In the current study, we hypothesized that TLR4 activation affects the healing of calvarial 
defects, and that different gene expression patterns would be observed between wild-type (WT) 
and Toll-like receptor 4 mutant (TLR4
-/-
) mice during the healing process. To test this 
hypothesis, we assessed bone healing in small calvarial defects created in WT and TLR4
-/-
 mice 
using radiographic, histologic and gene expression analyses. 
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2.2 MATERIALS AND METHODS 
2.2.1 Animal Care and Experimental Design 
Wild-type C57BL-6J mice (Jackson, Bar Harbor, ME) and TLR4
-/-
 mice (from an ongoing 
breeding colony housed at the University of Pittsburgh) between 10 and 12 weeks of age (20-30 
g) were used in this study. Mice were randomly chosen for radiographic, histological, or RT-
PCR analyses. All mice were maintained in the Rangos Research Center Animal Facility, 
Children’s Hospital of University of Pittsburgh with a 12:12 h light-dark cycle and free access to 
standard laboratory food and water. All procedures were carried out in accordance with the 
regulations regarding the care and use of experimental animals published by the National 
Institutes of Health and were approved by the Institutional Animal Care and Use Committee of 
the University of Pittsburgh. 
2.2.2 Calvarial Defects Models 
Mice were anesthetized by inhalation with isoflurane (4% for induction, 2% for maintenance, 
Abbott Laboratories, Chicago). The scalps were depilated and cleaned prior to surgery. Under 
sterile conditions, the calvariae were exposed by midline scalp incision and the periosteum 
covering the entire parietal bone was stripped off. A circular parietal defect was made using a 1.8 
mm outer diameter trephine (Fine Science Tools, Foster City, CA). The calvariae were irrigated 
with PBS during surgery. Following creation of the defect, the scalp was reapproximated and 
closed with 4-0 Vicryl resorbable sutures and 1 mg/kg ketoprofen (Fort Dodge Animal Health, 
Fort Dodge, IA) was administered as an analgesic immediately after surgery. All animals were 
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euthanized by CO2 overdose followed by cervical dislocation at designated time points 
postoperatively. 
2.2.3 Histologic Analyses 
Between three and five mice from each group were euthanized on untreated day 0 and 
postoperative days 1, 4, 7, 14, 21 and 28. Calvariae and surrounding soft tissues (e.g., skin, 
brain) were harvested by cutting the skull bones anteriorly across the middle of the frontal bones 
and posteriorly through middle of the interparietal bone. The samples were fixed in 10% neutral 
buffered formalin for 24-48 h and were decalcified overnight in Cal-Ex decalcifer (Fisher 
Scientific, Hampton, N.H.) prior to being dehydrated through a series of alcohols and embedded 
in paraffin. Paraffin-embedded specimens were sectioned through the coronal plane at a 
thickness of 5 µm. Three regions of each defect, 50 µm apart, were cut and placed on slides (for 
a total of approximately 30 slides per animal). Slides were stained with Harris’ hematoxylin & 
eosin (Surgipath Medical Industries, Richmond, IL) for conventional, qualitative bright-field 
light microscopy.  
Histomorphometric analysis was performed to quantify the two-dimensional area of new 
bone formation. Healing data was calculated based on three to five slides per animal. 
Microscopic images of the histologic sections under 100X were analyzed using Northern Eclipse 
software (Empix Imagine, Inc., Mississauga, Ontario, Canada). New bone area was calculated as 
the sum of the areas of each bone section, including within the defect and on both sides of 
calvarial. Data were expressed as mean +/- SEM. 
Russell-Movat pentachrome staining (American MasterTech, CA) was performed to 
further differentiate the following tissues within the defect: hematoma/fibrin (intense red), elastic 
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fibers (black), cartilage (deep green), granulation/ fibrous tissue (green or light blue) formation 
and degradation, newly-formed woven bone (yellow) and lamellar bone (red). All specimens 
were examined at 25 X, 50 X, 100 X and 200 X magnifications.  
Immunohistochemistry stain: Sections were deparaffinized with xylenes and rehydrated 
through serial of EtOH dilutions to distilled H2O. Following the manufacturer’s instructions, 
sections were incubated in  primary goat polyclonal anti-OPN (Santa Cruz Biotechnology, Santa 
Cruz, CA) as a marker of osteogenic differentiation  suspended at a 1:250 dilution in 2% normal 
horse serum (Vector Laboratories, Burlingame, CA) for 30 min at room temperature, secondary 
antibody (biotinylated anti-goat, made in horse, BA-9500, Vector Laboratories, Inc. CA, USA) 
diluted at 1:250 for 30mins at room temperature, and with Streptavidin-HRP ( R&D systems, 
Gaithersburg, MD) at dilution 1:500 for 30mins at room temperature. Color was developed by 
application of DAB kit (Vector Laboratories, Burlingame, CA). Sections were dehydrated and 
mounted prior to examination at 25 X, 50 X, 100 X, and 200 X magnifications. 
2.2.4 Radiographic Analysis 
Ten animals from each group were euthanized 28 days after surgery and calvariae were 
harvested and fixed in 10% neutral buffered formalin for 24-48 hours. Radiographs were 
obtained using a Faxitron MX-20 (Faxitron X-Ray, Lincolnshire, IL) with a 35 Kv exposure and 
a 45-second exposure time to analyze calvarial healing. The films (Eastman Kodak, Rochester, 
NY) were developed and scanned using a Microtek 9800 XL scanner (Microtek Lab, Inc., 
Fontana, CA). The scanned images were imported into Northern Eclipse software (Empix 
Imagine, Inc., Mississauga, Ontario, Canada). The remaining defect area was measured, and 
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subtracted from the geometric original defect area (2.54mm
2
) to generate the area of newly-
formed bone. 
2.2.5 mRNA Extraction and Expression Analysis 
Five to seven mice from each group per time point were killed at day 0 before surgery and at 3h, 
days 1, 2, 4, 7, 14, 21, 28 postoperatively. Samples surrounding the initial 1.8 mm defect were 
collected using a 5.0mm trephine (Fine Science Tools, Foster City, CA), and included blood 
clots, hematoma, granulation tissue, new bone and surrounding normal bone. Samples were 
stored at 4°C in RNAlater solutions (Life Technologies, NY) until ready for RNA isolation. The 
specimens were homogenized in liquid nitrogen using a mortar and pestle, and RNA was 
extracted from the sample using RNAqueous-Micro Kit (Life technologies, NY) and the 
manufacturer’s protocol. Contaminating genomic DNA was eliminated by treatment with 
DNAse I (Invitrogen, Life Technologies). Primers used in the study recognize IL-1, IL-1, IL-
6, TNF-, BMP-2, BMP-4, TGF-β1, TGF-β2, TGF-β3, VEGF, PDGF, RANK, RANKL and 
OPG. The housekeeping genes GAPDH and EEF2 were chosen as internal controls. RT-PCR 
results were analyzed by standard curve analysis. Finally, relative gene expression in WT and 
TLR4
-/-
  mice was compared at designated time points. 
2.2.6 Statistical Analysis 
Statistical analyses were performed using SPSS v.20.0 software (SPSS, Inc, Chicago, IL). Mean 
areas of newly-formed bone collected from histomophometric measurements were compared 
using a group by time point (2 x 4) two-way ANOVA followed by group by time point (1 x 4) 
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split plot one-way ANOVAs to compare each group (either WT or TLR4
-/-
) over time. Post-hoc 
LSD tests for multiple comparisons were used to detemine significant differences among groups 
and time points. Independent t-tests were performed to compare histomorphometric and 
radiographic measurements of newly-formed bone area in WT and TLR4
-/-
 mice at each time 
point. 
PCR data violated the assumption of homogeneity of variance, so the data was 
transformed  using a rank transformation. Data were compared using two-way (time x group) 
ANOVA and are compared according to “early”( ≤4 days) and “late”(>4 days) time point 
groups. A p value less than or equal to 0.05 was considered significant.  
 
2.3 RESULTS 
2.3.1 Histological Analysis 
2.3.1.1 Qualitative histologic analysis 
Day 0: Similar histological staining was shown in WT and TLR4
-/-
 mice on day 0 using H&E 
and Pentachrome stain (Figure. 1A, B; Figure. 2A, B). 
Day 1-day 4: WT and TLR4
-/-
 mice showed similar histological staining patterns on day 1 
and day 4 (Figure. 1C, D; Figure. 2C, D). Hematoma was visible and infiltration by multiple cell 
types was observed  in H&E stained images. The bone defect was filled with hematoma as early 
as day 1. No changes were observed in the periosteal regions on day 1 (Figure. 1C, D). Evidence 
of hematoma degradation and a reduction in cellular infiltrate was apparent by day 4. On the 
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endocortical surface (presumably derived from the dura mater), cells gathered along the 
perimeter of the defect (Figure. 1E, F). Dural cell layer was thicker and OPN staining intensity 
were more pronounced in TLR4
-/-
 mice than in WT mice (Figure. 3A, B). No bone formation 
was evident on day  4. 
Day 7-day 14: Larger areas of newly-formed bone were seen in TLR4
-/-
 mice than in WT 
mice on day 7. Newly-formed cellularized bone matrix, indicated by positive saffron yellow 
staining (Figure. 2E, F), was observed on the endocortical (dural) side of the calvarial bone 
lateral to the defect perimeter in both WT and TLR4
-/-
 mice. The thickness of the dural cell layer 
was diminished relative to day 4, and there was evidence of active bone formation near the dural 
side of the calvaria. Disorganized loose connective tissue completely filled the bone defect on 
day 7 (Figure. 1G, H). OPN immunoreactivity was observed along the ectocortical bone surface 
(periosteal side), along the endocortical bone surface (dural side), within the intercortical region 
(bone marrow or diploic space), and along the defect margins. OPN immunostaining was more 
intense in TLR4
-/-
 mice than WT mice (Figure. 3C, D). Typical large, rounded osteoblasts were 
recognized on the surface of the newly-formed bone in WT and TLR4
-/-
 mice on day 14 (Figure. 
3E, F). Regenerated bone was seen along the dural surface of the calvarial bone and along the 
defect perimeter. Periosteal thickness remained unchanged between days 7 and 14, while the 
loose connective tissue was thinner and more organized (Figure. 1I, J). 
Day 21-day 28: Defects in WT and TLR4
-/-
 mice were histologically similar during this 
period. On day 21, active bone formation was suggested by the presence of large regions of 
woven bone matrix at the defect margin in WT and TLR4
-/-
 mice (Figure. 1K, L). Mature OPN-
positive osteoblasts were observed on the surfaces of the woven bone. Dural cell layers returned 
to day1 thickness  without OPN positive staining (Figure. 3G, H). On day 28, less OPN positive 
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staining and less bone formation was detected in both WT and TLR4
-/-
 mice (Figure. 1M, N; 
Figure. 3I, J). Bone remodeling was evident with acid fuchsin red positive staining (Figure. 2G, 
H). Periosteum and soft connective tissue became much thinner, more dense, and better 
organized (Figure. 1M, N). 
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Figure 1: Histophotomicrographs for H&E stained tissues at the defect margins at postoperative time points 
WT and TLR4
-/-
 mice showed similar histological staining patterns on days 0, 1 and 4, while larger areas of 
newly-formed bone were seen in TLR4
-/-
 mice than in WT mice on day 7. Newly-formed cellularized bone matrix 
was observed on the endocortical (dural) side of the calvarial bone lateral to the defect perimeter in both groups 
since day 7. Active bone formation was suggested by the presence of large regions of woven bone matrix at the 
defect margin in both groups on days 14 and 21. Defects in WT and TLR4
-/-
 mice were histologically similar since 
day 21. (scale bar: 100 µm; bolded arrows: defect margin; endo: endocortical surface of calvarial bone; ecto: 
ectocortical surface of calvarial bone; H: hematoma; IC: infiltrating cells; LB: lamellar bone; WB: woven bone; 
NFB: newly-formed bone; DC: dural cells) 
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Figure 2: Histophotomicrographs of slides stained with OPN antibodies using immunohistochemistry 
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OPN staining intensity were more pronounced in TLR4-/- mice than in WT mice on postoperative days 4 and 7.  
Typical large, rounded osteoblasts were recognized on the surface of the newly-formed bone in both groups on day 
14 . On day 28, less OPN positive staining was detected in both WT and TLR4
-/-
 mice. (scale bar: 100 µm; bolded 
black arrows: defect margin; LB: lamellar bone; WB: woven bone; OPN(+): OPN positive stains; OB: osteoblasts)  
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Figure 3: Histophotomicrographs of pentachrome stained tissues in WT and TLR4
-/-
 mice 
Similar stains were observed between WT and TLR4
-/- 
mice on day 0 and day 1. An increased amount of newly-
formed bone was observed in TLR4
-/-
 mice at day 7, suggesting accelerated healing compared to WT. Lamellar bone 
(*), which stains positive for acid fuchsin (red) was observed in both groups on day 28, suggesting maturation and 
remodeling of the newly formed bone matrix. (scale bar: 100 µm; bolded black arrows:  defect margin; LB: lamellar 
bone; NFB: newly-formed bone)  
2.3.1.2 Quantitative histologic analysis 
No obvious bone formation was observed in either group before day 7. Two-way ANOVA 
comparing mean newly-formed bone areas showed a significant group by time point interaction 
(F=3.476; p<0.05) and significant group (F=5.946; p<0.05) and time point (F=14.728; p<0.05) 
effects. One-way ANOVA showed no significant differences in bone healing between days 21 
and 28 in WT mice, or between days 14, 21, and 28 in TLR4
-/-
 mice (p>0.05). Independent T-
tests showed significant differences in newly-formed bone areas between WT and TLR4
-/-
 mice 
on both days 7 and 14 (p<0.05, Figure. 4). Larger newly-formed bone areas were observed in 
TLR4
-/-
 mice on days 7 and 14, although comparable levels of bone healing were observed in 
both groups at other time points (p>0.05; Figure. 4). 
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Figure 4: Graph showing newly-formed bone areas measured from H&E stained histology slides 
No obvious bone healing was seen before day 7. Significant differences in bone healing areas were observed 
between WT and TLR4
-/-
 mice on days 7 and 14 postoperatively. Newly-formed bone areas were not significantly 
different after day 21 in WT mice or after day 14 in TLR4
-/-
 mice (mean +/- SEM ; *p<0.05). 
2.3.2 Radiographic Analysis 
Mineralized tissue was observed on day 28 radiographs in WT and TLR4
-/-
 mice, although 
healing remained incomplete during the 28 days of observation. Calculation of newly-formed 
bone area as determined by radiography revealed healing percentages of 33.14% and 26.83% 
(data not shown) in WT and TLR4
-/-
 mice, respectively. Independent T-test showed no 
significant difference in bone healing area between WT (0.9378+/-0.1131mm
2
; 33.14% healing) 
and TLR4
-/-
 (0.6814+/-0.209mm
2
; 26.83% healing) mice on day 28 (p>0.05, Figure. 5). 
 35 
 
Figure 5: Graph showing similar amounts of radiographically opaque tissue observed on day 28 in both 
groups 
Independent t-test showed no significant differences between the calvarial healing of WT and TLR4
-/-
 mice at this 
time point. Out of 20 mice tested, none showed complete healing during the 28 days of observation. (mean +/-SEM; 
n=10 each). 
2.3.3 Gene Expression 
Baseline expression of 14 genes (IL-1α, IL-1β, Il-6, TNF-α, BMP2, BMP4, TGF-β1, TGF-β2, 
TGF-β3, VEGF, PDGF, RANK, RANKL, and OPG) were measured by quantitative RT-PCR 
using day 0 untreated samples. Expression of IL-1β and VEGF was significantly different 
between the two groups.IL-1β (24.52 +/-16.79 copy in WT; 5.30+/-1.46 copy in TLR4-/-) and 
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RANKL (6.90e-3 +/-4.10e-3 copy in WT;1.80e-3+/-5.00e-4 copy in TLR4
-/-
) expression were 
higher in WT mice, and VEGF (32.42+/-15.90 copy in WT; 92.39+/-1.64 copy in TLR4
-/-
) 
expression was higher in TLR4
-/-
 mice on day 0 (Figure. 6). 
 
Figure 6: Graph showing quantitative gene expression on day 0 (untreated control) bone tissue 
Siginificant differences were identified in the expression of IL-1β,VEGF and RANKL between the two groups. IL-
1β and RANKL expression were higher in WT mice and VEGF expression was higher in TLR4-/- mice on day 0 
(mean +/-SEM; n=5 to 7; *p<0.05). 
 
Changes in gene expression at designated time points were determined by relative RT-
PCR. The gene expression patterns for IL-1α, IL-1β and TNF-α expression were similar in both 
groups. Expression of these cytokines increased after surgery, remained stable for a few days and 
then was upregulated on day 14 and day 21 postoperatively. Significantly higher expression of 
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IL-1β was detected by two-way ANOVA analysis at both early (F=8.414, p<0.05) and late 
(F=26.17, p<0.001) time points in TLR4
-/-
 than in WT mice. TNF-α expression was significantly 
higher at early time points in TLR4
-/-
 mice compared to WT mice (F=6.451, p<0.05) (Figure. 7A, 
B, D). IL-6 exhibited a different expression pattern in TLR4
-/-
 mice, and showed significantly 
higher fold change expression  than in WT mice at early time points postoperatively (F=6.685, 
p<0.05) (Figure. 7C). 
 
Figure 7: Graph showing relative fold change expression of inflammatory cytokines for WT and TLR4
-/-
 mice 
The fold change patterns in IL-1α, IL-1β, and TNF-α expression were similar in both groups. IL-6 had a different 
expression pattern in TLR4
-/-
 mice compared to WT mice at early time points (mean fold change over day 0; ND, 
not detectable; mean +/-SEM; n=5 to 7). 
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BMP2 expression increased slightly after surgery in both groups,  peaking at day 14 
(3.28+/-1.02 fold in WT;1.59+/-0.81 fold in TLR4
-/-
) and declining thereafter. No significant 
difference in BMP2 expression was observed between the two groups (Figure. 8A). BMP4 
expression was similar in both groups, increasing slightly until day 21 (87.06+/-72.08 fold in 
WT; 128.27+/-80.39 fold in TLR4
-/-
) and declining at day 28 (18.24+/-13.53 fold in WT; 2.56+/-
1.77 fold in TLR4
-/-
). No significant difference in BMP4 expression was observed between the 
two groups (Figure. 8B).  
Significant differences of TGF-β1 were observed in TLR4-/- mice compared to WT mice 
at early time points (F=22.636, p<0.001) (Figure. 8C). No significant differences were detected 
in the expression of TGF-β2 between groups (Figure. 8D). A similar pattern in TGF-β3 
expression was observed in both groups. Expression remained stable between 3h and day 7, and 
achieved a peak in expression at day 14 (12.69+/-3.55 fold in WT; 26.42+/-10.58 fold in TLR4
-/-
). While the pattern of TGF-β3 expression was similar between the two groups, significantlly 
higher expression of  TGF-β3 was observed in TLR4-/- mice than in WT mice (F=15.283, 
p<0.001)(Figure. 8E). The fold change expression patterns of VEGF and PDGF in WT and 
TLR4
-/-
 mice were similar. Expression of VEGF in WT and TLR4
-/-
 remained relatively constant 
until it was upregulated at day 14 (7.90+/-5.25 fold in WT;1.17+/-0.02 fold in TLR4
-/-
), and 
began to decrease thereafter. Significantly lower expression of VEGF  was detected in TLR4
-/-
 
mice than in WT mice (F=31.258, p<0.001). PDGF expression was stable in both WT and TLR4
-
/- 
mice at all time points. Significantly higher expression of PDGF was observed in TLR4
-/-
 mice 
compared to WT mice at early time points (F=4.157, p<0.05) (Figure. 8F, G). 
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Figure 8: Graph showing relative fold change expression of growth factors for WT and TLR4
-/-
 mice 
Similar expression patterns of BMP2, BMP4, TGF-β2, VEGF, and PDGF were observed between the two groups. 
Higher expression levels of TGF-β1 and TGF-β3 were detected in TLR4-/- mice than in WT mice at early time 
points (mean +/-SEM; mean fold change over day 0; ND, not detectable; n=5 to 7). 
 
High expression level of RANK was detected on day 14 in WT mice (16.50+/-15.94 
fold), while expression level in TLR4
-/-
 was similar at all time points. Fold change expression of 
RANK in TLR4
-/-
  was significantly lower than in WT mice at both early (F=4.453, p<0.05) and 
late time points (F=6.522, p<0.05) (Figure. 9A). Expression patterns of RANKL and OPG were 
relatively stable in WT mice. In TLR4
-/-
 mice,  both RANKL and OPG were slightly increased at 
early time points (≤4 days) and decreased at day 7. Expression level of RANKL was 
significantly higher in TLR4
-/-
 mice at early time points (F=4.199, p<0.05) and significantly 
lower at late time points compared to WT mice (F=56.217, p<0.001). Fold change expression of 
OPG in TLR4
-/- 
 was significantly lower than in WT mice at late time points (F=83.961, 
p<0.001). (Figure. 9B, 9C). 
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Figure 9: Graph showing relative fold change expression of RANK, RANKL and OPG for WT and TLR4
-/-
 
mice 
Expression levels of RANK, RANKL and OPG were realtively constant in WT at all time points. Greater variation 
of the three genes was detected in TLR4
-/- 
(mean +/-SEM; n=5 to 7). 
2.4 DISCUSSION 
Inflammation has a complex role in fracture repair, although the underlying mechanisms remain 
unclear 
105-107
. TLR4 is a member of a highly conserved receptor family and is a critical activator 
of the innate immune response after tissue injury. TLR4 signaling has been shown to regulate 
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both the immune response and bone metabolism during long-bone fracture healing. Here, we 
tested the hypothesis that TLR4 activation limits the healing of calvarial defects. 
In this study, a smaller than “critical-size” calvarial defect model was used, which by 
definition, would be expected to heal spontaneously over the duration of the observation. 
However, none of our 1.8mm diameter defects healed complete during 28 days of observation. 
The maximum healing was approximately 30% of the original defect area, which is consistent 
with previous observations by Gosain et al., who observed 27-35% healing of critical-size 
defects at 4 weeks 
108
. Importantly, we found that no significant healing occurred after 21 days in 
this model. Pentachrome staining of day 28 defects supports this observation. The newly-formed 
woven bone adjacent to the defect perimeter stained with acid fuchsin red, suggesting that bone 
remodeling had already taken place by day 28. OPN reactivity suggests that bone formation, 
which was highly active around day 21 in WT mice and day 14 in TLR4
-/-
 mice, became less 
active and less OPN-positive staining was observed. Thus, there may exist a temporal window 
for mature calvarial healing even in defects smaller than “critical-size”. The molecular signaling 
involved in the cessation of bone formation within such bone defects need to be further 
characterized.  
Although no significant difference in total calvarial healing was observed between groups 
radiographically or histologically on post-operative day 28, accelerated healing was observed in 
TLR4
-/-
 mice. By day 4, a thicker dural cell layer and more dense OPN positive stains were 
evident in TLR4
-/-
 mice. By day 7, a quantity of newly-formed woven bone was seen on the 
endocortical calvarial surface in TLR4
-/-
 mice. Quantitative histomorphometry data was 
consistent with the histological findings mentioned above. Two-way ANOVA comparing mean 
newly-formed bone areas showed a significant group by time point interaction, suggesting that 
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the WT and TLR4
-/-
 mice healed differently over time. It showed significantly larger area of new 
bone in TLR4
-/-
 mice on day 7 and day 14. Similarly, improved bone healing has been reported 
for long bone fracture healing in mice lacking an adaptive immune system. Specifically, in 
RAG1
-/-
 mice (recombination activating gene 1 knockout), increased bone formation and 
biomechanical strength at early time points was associated with reduced pro-inflammatory 
cytokine expression and increased expression of the anti-inflammatory cytokine, IL-10 
98
. Those 
observations suggest that the suppression of the adaptive immune system might maximize the 
regenerative and minimize the destructive effects of inflammation which may promote fracture 
repair 
98
. In our model, bone healing was obviously accelerated in TLR4
-/-
 mice, although the 
total bone healing achieved was comparable between two groups. Whether accelerated calvarial 
healing effect is due to the suppression of TLR4-mediated inflammatory response requires 
further exploration. 
Gene expression analysis showed that expression of inflammatory cytokines, generally, 
was elevated 3 hour post-operatively, and a second spike in inflammatory gene expression was 
detected around day 14 in both groups. Greater variation was detected in the expression of 
growth factors after surgery. These findings are consistent with the gene expression patterns 
described in long bone fracture models 
74,109
. Of greater interest, we found that IL-1β, IL6 and 
TNF-α,TGF-β1, TGF-β3 and PDGF were more highly expressed at earlier time points in TLR4-/- 
mice. We speculated that accelerated bone healing observed in TLR4
-/-
 mice might, at least in 
part, be due to earlier and higher expression of these genes 
110-112
.  
The inflammatory cytokines IL-1β, IL-6 and TNF-α have complex effects on bone 
regeneration. IL-1β can stimulate osteoblasts and bone matrix formation, but also suppress the 
differentiation of mMSCs 
113
.
 
 In vivo studies in IL1α, IL1β, and IL1αβmutant mice have 
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shown impaired osteoclast development to result in increased bone density and femoral bone 
mass within these animal models 
114
. IL-6 has been shown to both promote and inhibit 
osteoclastogenesis 
115,116
.
 
An in vivo study determined that the absense of IL-6 promoted 
inflammatory calvarial bone loss in a mouse model
117
. Although IL-6
-/-
 mice showed reduced 
osteoclastogenesis and impaired callus strength at the early time points after surgery, similar long 
bone healing outcomes were observed in comparison with WT mice after 3 weeks 
118
.
 
Therefore, 
the role of IL-6 in osteoclastogenesis has been more elucidated 
117,118
.
 
Further studies are needed 
to understand the impact of TLR4-mediated inflammatory and related inflammatory cytokines 
expression on calvarial bone repair. 
RANK, OPG and RANKL are important mediators of remodeling during bone formation 
and bone regeneration. TLR signaling inhibits RANKL-mediated osteoclastogenesis, although 
TLR activation can also promote osteoclastogenesis by inducing RANK and TNF-α expression 
in osteoblasts
100
. In the present study, significant differences were apparent in the  expression of 
RANK, OPG and RANKL between TLR4
-/-
 and WT mice.  Expression of RANKL was 
significantly higher in TLR4
-/-
 mice compared to WT mice at early time points. RANK, RANKL 
and OPG all showed significantly lower expression in TLR4
-/-
 mice than in WT mice at late time 
points. During long bone regeneration, upregulated RANKL at primary long bone formation 
stage is associated with mineralized cartilage resorption and bone formation, and downregulated 
expression indicated bone remodeling. Early high expression levels in TLR4
-/-
 mice suggest early 
and high resorption activity of osteoclasts. The differential expression of these three genes might 
explain the observed accelerated bone formation and early bone remodeling in TLR4
-/-
 mice.  It 
remains unclear whether differenes in RANK, RANKL and OPG expression are directly linked 
to the absence of TLR4 signaling. 
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Conclusion:  The present study revealed accelerated bone formation and bone remodeling 
in absence of TLR4 signaling pathway. This phenotype is also associated with changes of local 
inflammatory cytokines and osteoclastogenic factors expression. Further work is required to 
determine whether regenerative effects of inflammation mediated by absence of TLR4 may lead 
to accelerated skull bone repair. 
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3.0  DENDRITIC CELL-EXPRESSING TLR4-MEDIATED MYD88 SIGNALING IS 
DETRIMENTAL TO CALVARIAL BONE HEALING 
3.1 INTRODUCTION 
Craniofacial skeletal injuries have made a tremendous economical, biological and social impact, 
with over 2 million head injuries and an estimated 592,000 surgeries annually in the United 
States
1,7
. Clinical management of craniofacial trauma remains highly challenging, thus, various 
efforts have been undertaken to develop and improve existing therapies for craniofacial 
reconstruction. Among these efforts, harnessing and modulating inflammation to facilitate bone 
regeneration has become a promising strategy 
119
. The inflammatory response is characterized by 
local activation of the innate immune system and is increasingly recognized for its essential role 
not only in host defense against infection but also in tissue regeneration and repair 
75,76
. The 
inflammatory response following wound injury is critical for the initiation of healing cascades, 
serving to recruit inflammatory and progenitor cells as well as to promote angiogenesis 
90
. 
Mounting evidence indicates that the wound-induced inflammatory response is among the 
earliest events to determine the quality 
120
 of the healing response in models of ischemia-
reperfusion injury, traumatic tissue injury, and musculoskeletal injury 
90,121,122
. As a result, 
efforts have been made to improve therapeutic strategies for skull repair, particularly under 
conditions in which healing is impaired or inefficient, either by enhancing the regenerative 
 47 
effects or by inhibiting the destructive effects of inflammation. Therefore, understanding the 
molecular mechanisms behind inflammation and skeletal regeneration should provide an avenue 
for intervention after skeletal trauma, allowing the inflammatory response to be modulated with 
precision to augment bone healing 
90
.   
Toll-like receptors (TLRs) are important mediators of the immune response that 
recognize a wide range of pathogen-associated molecular patterns (PAMPs) and damage-
associated molecular patterns (DAMPs) in response to infection, injury, stress, and cellular 
necrosis 
123
. In addition to their roles in host defense against microbial infection, TLRs are also 
involved in tissue fibrosis, tissue homeostasis, and wound healing in the neuronal, digestive, 
cardiovascular, and musculoskeletal systems, through multiple mechanisms including limiting 
the extent of initial tissue injury or stimulating the repair cascade 
123
. Myeloid differentiation 
primary response gene 88 (MyD88) and TIR-domain-containing adapter-inducing interferon-β 
(TRIF) are the two main adaptor proteins of TLR signaling that mediate downstream pathways 
including NF-B, IFN regulatory factor-1, and MAP kinases 123. While most TLRs often utilize 
only the MyD88 pathway, TLR4 is unique in that it also utilizes the TRIF pathway 
124
.    
Distinction has been made in the contribution of MyD88- and TRIF-mediated signaling 
pathways to TLR4-driven responses to injury. TLR4 signaling through different pathways can 
have either damaging or protective effects depending on tissue, mode of injury, or mode of 
activation. For example, studies have demonstrated that MyD88 signaling contributes to 
ischemic brain damage
125-127
, and hind limb ischemia
128
, whereas TRIF-mediated signaling 
exerts a neuroprotective effect against cerebral ischemia
129
. Conversely, in models of cardiac and 
pulmonary injury, radiation-induced lung injury
130
, and intestinal ischemia
131
, MyD88-dependent 
signaling has protective effects. In short, the functional consequences of TLR activation on tissue 
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homeostasis and regeneration are strongly dependent upon organ setting, mode of activation, and 
mode of injury. As such, understanding the mechanistic aspects of TLR signal transduction 
during bone healing will be crucial for appreciating their contributions to tissue regeneration at 
the cellular level. 
Studies have shown an essential involvement of TLRs in skeletal homeostasis, however 
specific cellular contribution is unknown. Multiple cell types are involved in injury-stimulated 
bone regeneration 
105
, such as inflammatory cells (platelets, macrophages, lymphocytes, and 
granulocytes) which migrate into the fracture hematoma and regulate inflammation as well as 
tissue regeneration 
132
. For example, dendritic cells regulate the highly pathogen-specific 
adaptive immune responses and are critical in the development of immunologic memory and 
tolerance 
133
. Macrophages infiltrate into the wound bed within 48-96 hours after injury, 
participating in the inflammatory response and debridement process via phagocytosis activity 
and reactive radical release. As TLR expression was primarily found in immune cells, such as 
macrophage and dendritic cells 
134-136
, understanding how lineage-specific TLR activation in 
regulating inflammation and skeletal homeostasis upon injuries may provide insight into the 
mechanisms of inflammation in bone regeneration and repair under various clinical settings. 
Studies have showed an essential role of TLR activation in inflammatory-induced bone 
destruction, however their direct influence on calvarial bone healing has not yet been thoroughly 
investigated. In a previous study (chapter 2), we showed accelerated bone healing with higher 
expression of osteoclastogenesis gene, RANKL, in TLR4 KO (TLR4
-/-
) mice compared to wild-
type (WT) mice within a calvarial defect model 
78
. Given that TLRs are implicated in 
inflammation-asssociated bone regeneration and disease 
137-139
, we employed KO mouse models 
for TLR2 and TLR4 and their intracellular mediators (MyD88 and TRIF). In addition, since 
 49 
enhanced osteoclastogenesis was implicated in TLR4
-/-
 mice in our previous findings 
78
 and 
osteoclasts are generated from myeloid and dendritic cells, we used cell-specific KO mouse 
models in which TLR4 expression was deleted in myeloid cells (Lyz-TLR4
-/-
) and dendritic cells 
(CD11c-TLR4
-/-
) separately as a means to study the cellular influences on calvarial bone healing. 
We hypothesized that a similar faster healing response would be observed in these KO mice 
models. The data presented here demonstrate an accelerated healing response in TLR4-deficient 
mice (TLR4
-/-
, Lyz-TLR4
-/-
 and CD11c-TLR4
-/-
) at post-operative day 7 and enhanced bone 
healing in MyD88
-/-
 and CD11c-TLR4
-/-
 mice at day 28. This suggests a detrimental role of 
dendritic cell-expressing TLR4-mediated MyD88 signaling in calvarial bone healing. 
3.2 MATERIALS AND METHODS 
3.2.1 Mouse Strains and Derivation 
WT mice were obtained from the Jackson® Laboratory (Bar Harbor, Maine). TLR4
-/-
, TLR2 KO 
(TLR2
-/-
), myeloid lineage-specific TLR4 KO (Lyz-TLR4
-/-
), dendritic-specific TLR4 KO 
(CD11c-TLR4
-/-
), MyD88
-/-
, and TRIF
-/- 
mice mentioned in this study were generated from an 
ongoing breeding colony at the University of Pittsburgh as described 
134,140
. Female mice from 
all strains, between 10 and 12 weeks of age and 20-30 g weight were used in this study. All mice 
were maintained in the Rangos Research Center Animal Facility at Children’s Hospital of 
Pittsburgh of UPMC with a 12:12 hour light-dark cycle and free access to standard laboratory 
food and water. All procedures were carried out in accordance with regulations regarding the 
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care and use of experimental animals published by the National Institutes of Health and was 
approved by the University of Pittsburgh Institutional Animal Use and Care Committee. 
3.2.2 Surgical Procedure 
Mice were anesthetized with isoflurane (2% by inhalation) and their scalps were shaved and 
cleaned with Betadine. Under sterile conditions, a 1.8 mm circular bone defect was created in the 
skull parietal bone using a 1.8 mm outer diameter trephine as previously described 
78
. 1 mg/kg 
ketoprofen (Fort Dodge Animal Health, Fort Dodge, IA) was administered as an analgesic 
immediately and two days after surgery. Mice were euthanized via CO2 asphyxiation followed 
by cervical dislocation at post-operative day 7 and day 28.  
3.2.3 Live Micro-computed Tomographic (CT) Analyses 
Calvarial defect healing was analyzed using a live high-resolution CT system (Inveon microCT, 
Siemens, Germany). At postoperative days 7, 14, and 28, bone healing of WT, TLR4
-/-
, TLR2
-/-
, 
Lyz-TLR4
-/-
, CD11c-TLR4
-/-
, MyD88
-/-
, and TRIF
-/-
 mice (average 10 mice per group) were 
analyzed using live-CT with a fixed isotropic voxel size of 62.4 m. 3D images were 
reconstructed using Amira 5.4 3D software (FEI Visualization Sciences Group, Burlington, 
MA). Quantitative data were analyzed with OsiriX software with a global fixed threshold -330 
and a region of interest (ROI) of 0.4mm
220.9 mm was defined. Standard CT measurements 
(regenerated bone volume (BV) = BV within ROI at day 7, 14 and 28 – BV at day 0) were 
calculated for each sample using OsiriX software. 
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3.2.4 Histology and Histomorphometric Analysis 
All mice were euthanized on post-operative day 28. WT, TLR4
-/-
, Lyz-TLR4
-/-
, and CD11c-
TLR4
-/-
 mice were also euthanized at post-operative day 7. Calvariae and surrounding soft 
tissues (e.g., skin, brain) were harvested, and fixed in 4% neutral buffered paraformaldehyde for 
24 hours, and decalcified in 10% EDTA prior to dehydration through a series of alcohols and 
embedment in paraffin. Paraffin-embedded specimens were sectioned through the coronal plane 
at a thickness of 5-6 µm. Slides were stained with Harris’ hematoxylin & eosin (H&E) 
(Surgipath Medical Industries, Richmond, IL) for conventional, qualitative bright-field light 
microscopy. All specimens were examined at 25 X, 100 X, 200 X, and 400 X magnifications.  
Russell-Movat pentachrome staining (American MasterTech, CA) was performed to 
further differentiate the following tissues within the defect: hematoma/fibrin (intense red), elastic 
fibers (black), and granulation/fibrous tissue (green or light blue), newly-formed woven bone 
(yellow) and lamellar bone (red) formation and degradation. All specimens were examined at 25 
X, 50 X, 100 X and 200 X magnifications.  
Histomorphometric analysis was performed to quantify the two-dimensional area of new 
bone formation using a Leica MZ12 Stereo Zoom microscope and Northern Eclipse (v5.0) image 
analysis software (Empix Imagine, Inc., Mississauga, Ontario, Canada). Healing data were 
calculated based on three to five slides per animal. New bone area was calculated as the sum of 
the areas of each bone section, including within the defect and on both the endocortical and 
endocotical sides of calvarial bone.  
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3.2.5 Statistical Analyses 
Statistical analyses were performed using SPSS v.20.0 software (SPSS, Inc, Chicago, IL). 
Newly-regenerated bone volumes collected from CT analysis were compared using a group by 
time point (7 x 3) two-way ANOVA followed by group by time point (7 x 1) split plot one-way 
ANOVA and Post-hoc LSD tests to compare each group over time. Mean areas of newly-formed 
bone calculated from histomorphometric measurements were analyzed using one-way ANOVA 
and post-hoc LSD tests for multiple comparisons at each time point. 
3.3  RESULTS 
3.3.1 Enhanced Calvarial Bone Healing in CD11c-TLR4-/- and MyD88-/- mice at Day 28 
While no group showed complete bone healing of the 1.8 mm diameter defect within 28 days, 
mineralized tissue was observed around the defect margins of TLR4
-/-
, Lyz-TLR4
-/-
, and CD11c-
TLR4
-/-
 mice at day 7, suggesting a faster healing response (Fig.10A). Improved overall healing 
of calvarial defects was observed in CD11c-TLR4
-/-
 mice and MyD88
-/-
 mice compared to WT 
control mice at day 28 (Fig.10A). Detailed regenerated BV data from CT measurements of all 
groups at different time points is shown in Fig.10B. The greatest difference in bone healing was 
observed at day 7 (Fig.11C). Differences in healing were less pronounced at day 28 (Fig.11E). 
Two-way ANOVA of BV analyses showed that significant differences were detected within time 
interactions (day 7, day 14, and day 28, p<0.001), and within group interactions (all seven 
experimental groups, p<0.001), while no significant difference was detected within group by 
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time interactions. At post-operative day 7, one-way ANOVA analyses showed that BV 
measurements were significantly larger in the TLR4
-/-
 (0.141±0.019 mm
3
, p<0.05), Lyz-TLR4
-/-
 
(0.179±0.029 mm
3
, p<0.001) and CD11c-TLR4
-/-
 (0.183±0.021 mm
3
, p<0.001) groups than the 
WT group. At day 14, BV measurements were significantly larger in TLR4
-/-
 (0.223±0.035 mm
3
, 
p<0.05), Lyz-TLR4
-/-
 (0.231±0.032 mm
3
, p<0.05), CD11c-TLR4
-/-
 (0.254±0.021 mm
3
, p<0.05) 
and MyD88
-/-
 groups (0.227±0.062, p<0.05) compared to WT group. At post-operative day 28, 
BV measurements were significantly larger in CD11c-TLR4
-/- 
(0.43±0.025, p<0.05) and MyD88
-
/-
 groups (0.369±0.046, p<0.05) compared to the WT group (0.232±0.036 mm
3
) (Fig.11C-11E).  
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Figure 10: Live CT analyses of all mouse groups 
(A) Representative 3D reconstructions of calvarial defects in the transverse plane at postoperative days 7 and 28. 
Faster healing was evident in TLR4
-/-
, Lyz-TLR4
-/-
, and CD11c-TLR4
-/-
 mice as indicated by mineralized tissue 
around the defect edges on day 7. Smaller defect areas are shown in CD11c-TLR4
-/-
 and MyD88
-/-
 mice compared to 
WT mice on day 28. (B) Table shows the regenerated BV measurements based on CT analyses. (C-E) Two-way 
ANOVA analyses of regenerated BV-based CT measurements showed no significant differences within groups (all 
mouse groups) by time interactions (day 7, day 14, and day 28). One-way ANOVA analyses showed that BVs were 
significantly larger in TLR4
-/-
, Lyz-TLR4
-/-
, and CD11c-TLR4
-/-
 groups than the WT group at day 7; TLR4
-/-
, Lyz-
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TLR4
-/-
, CD11c-TLR4
-/-
, and MyD88
-/-
 groups than the WT group at day 14; and CD11c-TLR4
-/-
 and MyD88
-/-
 
groups compared to WT group on day 28. More detailed comparisons among groups at different time points are 
shown in Fig.2. (Scale: 500 m; BV: bone volume within region of interest (ROI); mean ± SEM; p<0.05 * 
compared to WT; # compared to TLR4
-/-
; ^ compared to TLR2
-/-
; % compared to Lyz-TLR4
-/-
; $ compared to 
CD11c-TLR4
-/-
; ~ compared to TRIF
-/-
; @ compared to MyD88
-/-
)  
3.3.2 Faster Intramembranous Bone Formation in TLR4-/-, Lyz-TLR4-/- and CD11c-
TLR4
-/-
 Mice 
Disorganized connective tissue completely filled the bone defect on day 7. Cellularized newly-
regenerated woven bone, indicated by positive saffron yellow staining, was observed mainly on 
the endocortical side of the calvarial bone lateral to the defect perimeter in all groups (Fig.11A). 
Typical large, rounded osteoblasts were recognized on the surface of the newly-formed woven 
bone of the three KO mice groups (Fig.11A). Pentachrome staining showed larger areas of 
newly-formed bone in TLR4
-/-
, Lyz-TLR4
-/-
, and CD11c-TLR4
-/-
 mice compared to WT mice on 
day 7 (Fig.11A). One-way ANOVA analyses showed significantly larger areas of newly-
regenerated bone area in TLR4
-/-
, Lyz-TLR4
-/-
, and CD11c-TLR4
-/-
 mice compared to WT mice 
on day 7 (p<0.05, Fig.11B). No significant differneces in newly-regenerated bone areas were 
observed among TLR4
-/-
, Lyz-TLR4
-/-
 and CD11c-TLR4
-/-
 groups. 
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Figure 11: Histology and histomorphometric analyses of calvarial bone repair at post-operative day 7 
(A) Representative pentachrome-stained images of WT and Lyz-TLR4
-/-
 mice on day 7. We used pentachrome-
stained images of Lyz-TLR4
-/-
 mice to represent TLR4
-/-
 and CD11c-TLR4
-/-
 groups (H&E stained images not 
shown). Larger areas of woven bone, indicated by saffron yellow staining, and more infiltration osteoblasts were 
observed in TLR4
-/-
, Lyz-TLR4
-/-
 and CD11c-TLR4
-/-
 mice compared to WT mice. (B) Histomorphometric analysis 
revealed larger areas of newly-regenerated bone in the three KO mice groups compared to the WT group. 
Comparable healing was observed in the three KO groups on day 7. (Scale bar: 50 m; bolded arrow indicated 
defect margin; Endo: endocortical side; Wo: woven bone; mean ± SEM; * p<0.05 compared to WT). 
 
All groups showed similar histological healing patterns and complete bone healing was 
not observed on post-operative day 28 (Fig.12, H&E stained images not shown). Periosteum and 
soft connective tissue became much thinner, more dense, and better organized on day 28. 
Regenerated bone was seen along the dural surface of the calvarial bone and along the defect 
perimeter. Typical rounded osteoblasts were less-recognized on the newly-formed bone surface 
compared to day 7. All groups showed bone remodeling as indicated with acid fuchsin red-
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positive staining (Fig.12A). One-way ANOVA analyses showed no significance of newly-
regenerated bone areas in all groups (Fig.12B). 
 
Figure 12: Histology and histomorphometric analyses of calvarial bone repair at post-operative day 28 
(A) Representative pentachrome-stained images. Similar healing was observed among all KO groups at day 28; thus, 
CD11c-TLR4
-/-
 mice were used to represent the rest of the KO mice. Periosteum and soft connective tissue became 
much thinner, denser, and better organized. Regenerated bone was seen along the dural surfaces of the calvarial 
bone and along the defect perimeter. Lamellar bone (*), which stains positive for acid fuchsin (red), was observed in 
both groups on day 28, suggesting maturation and remodeling of the newly formed bone matrix. (B) 
Histomorphometric analysis revealed comparable newly-regenerated bone area among all groups on day 28. (scale 
bar: 50 µm; bolded black arrows: defect margin; Endo: endocortical side; LB: lamellar bone). 
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3.4 DISCUSSION 
TLRs are critical activators of the innate immune response and are attractive therapeutic targets 
for inflammation-modulated tissue regeneration 
75,76
. The role of inflammation on long bone 
healing has been extensively investigated; however, its impact within craniofacial settings is not 
well understood. Here, we examined the calvarial bone healing in mice lacking important 
mediators of TLR signaling pathways, aiming to understand the role of TLR signaling on 
calvarial defect healing. Remarkably, we found that dendritic cell-expressing TLR4 might be 
detrimental to bone healing through MyD88 pathway, suggesting a regulatory role of these TLR 
pathway mediators in calvarial fracture repair.  
Studies have suggested important roles of TLR4/MyD88 and TLR2/MyD88 signaling 
pathways in regulating inflammation and bone metabolism in various osteolytic diseases 
141-144
, 
however their involvement in non-compromised fracture healing process has not been 
investigated. In this study, we observed the calvarial bone healing process in TLR2
-/-
, TLR4
-/-
, 
MyD88
-/-
, and TRIF
-/-
 mice. The fact that we did not observe differences of bone healing in 
TLR2
-/-
 and TLR4
-/-
 mice compared to WT mice at day 28, may be attributed to the ability of 
TLRs to reciprocally compensate for each other's loss of gene function
145,146
. For example, in a 
mouse cecal ligation puncture-sepsis model, TLR4 was overexpressed in TLR2
-/-
 mice compared 
to that in WT mice. Although TLR2
-/-
 and TLR4
-/-
 mice presented lower renal inflammatory 
cytokine expression, only MyD88
-/-
 mice were fully protected from damage caused by sepsis
145
. 
MyD88 is an important adaptor protein for the majority of TLR signaling. Therefore, loss of 
MyD88 function has a large impact on the downstream TLR signaling pathways including the 
immune response against pathogens and tissue regeneration after injury 
147,148
. The functional 
consequence of MyD88 signal loss may vary substantially depending on the organ setting and 
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mode of injury. For example, MyD88-deficient mice present with detrimental phenotypes 
including delayed wound healing phenotype, impaired epithelial regeneration, and decreased 
radiation survival in multiple mouse models of injury, but present advantageous phenotypes 
including decreased fibrosis and protection against cardiac hypertrophy after myocardial 
infraction 
149-153
. In our study, we showed that MyD88 has a detrimental role in bone 
regeneration because enhanced bone healing was observed in MyD88
-/-
 mice and not TRIF
-/-
 
mice compared to WT mice on day 28; thus, the accelerated bone healing phenotype observed 
within this model might not be TLR4/TRIF or TLR3/TRIF signaling dependent, but is instead 
mediated via MyD88-dependent pathway.  
In our previous study (chapter 2), enhanced osteoclastogenesis was implicated in 
accelerated skull healing in TLR4
-/-
 mice. We showed a faster bone healing response based on 
histological analysis with upregulated expression of RANKL in TLR4
-/-
 mice compared to WT 
mice 
78
. Since both myeloid and dendritic cells give rise to osteoclasts, we further dissectted the 
role of TLR4 signaling in these cells to understand their role in calvarial bone healing. To 
specifically knockout TLR4 expression in myeloid cells (Lyz-TLR4
-/-
) and dendritic cells 
(CD11c-TLR4
-/-
), the Cre-loxP technique was used in conjunction with lysozyme (lyz) and 
CD11c (cd11c) promoters, respectively. One limitation is that, while lyz is highly expressed in 
all myeloid cells, depletion of TLR4 in this model might also occur in a small population of 
CD11c+ dendritic cells. Previous studies have shown that this effect is negligible 
134,154
. 
Therefore, our myeloid and dendritic cell-specific knockouts enabled us to extend our previous 
findings with global TLR4
-/-
 mice, so that we can better understand the unique effect that TLR4 
signaling has on bone regeneration and repair. 
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In the current study, CT data further support our previous histomorphometric findings78 
showing TLR4
-/-
, Lyz-TLR4
-/-
, and CD11c-TLR4
-/-
 mice all exhibited accelerated bone healing 
phenotypes (Figure 11). Although TLR4 deficiency in both myeloid cells and dendritic cells 
contribute to a faster healing response, only the latter showed enhanced healing at a later time 
point (day 28). Previous studies suggested that dendritic cells differentiate into osteoclasts under 
the appropriate inflammatory conditions and may contribute to inflammation-induced 
osteoclastogeneis, however, how deficient dendritic cells mediate fracture repair is unknown 
155,156. It was recently revealed that immature dendritic cells (iDC) had an increased ability to 
form osteoclast-like multinucleated giant cells when compared to myeloid derived-monocytes in 
an inflammatory environment 
157,158
. We propose that the differences observed in healing in this 
study may be attributed to 1) differential osteoclastogenesis of macrophages and dendritic cells 
induced by TLR4 activation, or 2) different spatiotemporal-dependent roles of macrophages and 
dendritic cells expressing TLR4 during the four stages of bone repair. Further study is required to 
fully elucidate the relationship between TLR4 activation in macrophage and dendritic cells with 
osteoclastogenesis during bone healing. 
 In summary, we have demonstrated that TLR signaling components affect calvarial bone 
healing, establishing a link between the skeletal and immune systems during craniofacial fracture 
repair. The differential healing responses we observed in KO mouse models, suggests that the 
dendritic cell-expressing TLR4-mediated MyD88 signaling pathway might be detrimental for 
calvarial defect healing. However, further work is required to explore the changes in gene 
expression and cellular infiltration over time during the healing process, which will benefit our 
understanding of the role of TLR-mediated inflammation in bone regeneration. 
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4.0  TLR4 INACTIVATION IN MYELOID CELLS IMPROVE BONE HEALING 
THROUGH ENHANCED OSTEOCLASTOGENESIS 
4.1 INTRODUCTION 
Skeletal development and tissue regeneration utilize many similar molecular mechanisms, some 
of which lie dormant and only activate in response to injury. Inflammation, an integral 
component of the injury response, is involved not only in the host defense against infectious 
pathogens but also in tissue repair and regeneration, dynamically balancing its tissue-destructive 
and tissue-constructive properties 
75,76
.
 
For decades, osteoimmunology has overwhelmingly 
focused on investigating osteoclasts and metabolic bone disease as they relate to pathologic bone 
resorption. Recently, interest has increased in elucidating the positive interactions between the 
immune and skeletal systems during the fracture healing process. This is an important 
consideration for bone repair and reconstructive therapies, especially when the injury site is 
unduly compromised by trauma and/or infection. Therefore, studies have conducted to explore 
the modulation of fracture-induced inflammation for obtaining desirable bone healing outcomes. 
These studies include modulating the expression of inflammatory cytokines, chemokines, and 
growth factors (IL1, IL-6, IL-18, TNF-, Complement 3, TGF-, VEGF, stromal cell-derived 
factor); controlling cellular proliferation, infiltration, and activity (macrophage, lymphocytes, 
bone cells, various stem cells); and using pharmacologic approaches (cytokine-specific 
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antagonists, corticosteroids, non-steroidal anti-inflammatory drugs) 
119
. Such studies have 
increased our understanding of the relationship between immunity and skeletal regeneration, 
which provides evidence and experience for future clinical translation.
 
Toll-like receptors (TLRs) are a family of transmembrane receptors that activate the 
innate immune response by recognizing conserved molecular patterns of microbial products as 
well as endogenous ligands 
123
. TLR activation results in intracellular signaling cascades that are 
mediated by two main adaptor proteins – Myeloid differentiation primary response gene 88 
(MyD88), and TIR-domain-containing adapter-inducing interferon-β (TRIF). While most TLRs 
utilize only the MyD88 pathway, TLR4 is unique in that it can also utilize the TRIF pathway. 
TLR4 signaling is of particular interest in regenerative biology due to its pronounced impact on 
healing in diverse models of injury and sterile inflammatory disease 
159,160
. It can recognize a 
wide range of pathogen-associated molecular patterns (PAMPs) as well as damage-associated 
molecular patterns (DAMPs) including bacterial lipopolysaccharide (LPS)
161
 and endogenous 
molecules such as fibrinogen 
162
, fibronectin 
163
, heat shock proteins 60 and 70 
164
, -Defensin 2 
165
, and high mobility group protein B1 (HMGB1) 
166
.  
TLR4 is mainly expressed in immune cells, such as monocytes/macrophages, dendritic 
cells, T cells and B cells, as well as bone cells, such as osteoblasts and osteoclasts. While the 
expression of different TLRs vary with different stages of osteoclast differentiation, expression 
of TLR2 and TLR4 expression have been reported within all osteoclast-lineage cells 
167
. 
Understanding how TLR4 signaling regulates the inflammatory response and osteoclast 
differentiation after fracture may provide insight into mechanisms of bone remodeling and 
regeneration as a result of skeletal diseases or trauma. Studies have shown that TLR4 activation 
can either promote or inhibit osteoclastogenesis under different clinical settings
168-170
. For 
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example, TLR4 signaling is involved in osteoclast development during osteoporosis, and is 
critical for LPS-stimulated inhibition of osteogenic differentiation through inducing RANKL and 
TNF- in osteoblasts 101,102,171,172,173. Conversely, direct TLR signaling has also been show to 
inhibit RANKL-mediated osteoclast differentiation in vitro, via maintaining the phagocytic pro-
inflammatory activity of osteoclast precursors as well as inhibiting their differentiation into non-
inflammatory mature osteoclasts 
100,174
. The fact that TLR stimulation acts as a potent negative 
regulator of osteoclastogenesis contradicts with the observation that TLR activation is associated 
with excessive bone resorption in many inflammatory bone diseases 
102,151,152
. Thus, these 
contradictory results hint that TLRs may have a dual role of regulating the balance between 
immune response and bone metabolism under various settings. 
In our previous study, accelerated bone healing with higher expression of RANKL was 
observed in TLR4
 
knockout mice (TLR4
-/-
) within a non-compromised calvarial defect model 
78
.  
Based on this data, we proposed that TLR4 depletion would enhance osteoclastogenesis, 
ultimately leading to accelerated calvarial bone healing. To test this hypothesis, we utilized a 
cell-specific TLR4
-/-
 mouse model (Lyz-TLR4
-/-
) in which TLR4 expression was deleted in 
myeloid cells, as osteoclasts are derived from myeloid-lineage cells. In this study, Lyz-TLR4
-/-
 
mice showed a faster healing phenotype similar to TLR4
-/-
 mice basing on histomorphometric 
and CT analyses. Increased infiltration of osteoclasts were also similarly observed in both 
TLR4
-/-
 and Lyz-TLR4
-/-
 mice. Although similarities in osteoclastogenesis were observed 
between both TLR4 deficient mice, higher expression of BMP2, TGF-1, IL-, and TLR2 was 
also observed in TLR4
-/-
 mice compared to WT and Lyz-TLR4
-/-
 mice, suggesting involvement 
of other mechanisms for the faster bone healing response observed in TLR4
-/-
 mice. Our data 
show that TLR4 inactivation in myeloid cells enhanced osteoclastogenesis differentiation and 
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exhibited faster bone healing in a calvarial defect model. Our data, together with previous work 
linking TLR4 with bone destruction in inflammatory disease, highlights a potential role for 
TLR4 as an important immune mediator that modulates osteoclastogenic differentiation in 
various clinical settings.  
4.2 MATERIALS AND METHODS 
4.2.1 Mouse Strains and Generation of Myeloid-specific TLR4-/- Mice 
Wild-type (WT) (C57BL-6J, The Jackson
® 
Laboratory, Bar Harbor, Maine), TLR4
-/-
, Lyz-TLR4
-
/-
, and TLR4
loxp/loxp
 female mice between 10 and 16 weeks of age and 20-30 g were utilized in 
this study. Myeloid lineage-specific TLR4 knockout (KO) mice (TLR4
flox/-, lyz cre
 or Lyz-TLR4
-/-
) 
were developed by breeding TLR4
loxp/-; Lyz-cre
 mice with TLR4
loxp/loxp
 mice 
134
. Tail snips of 
offspring were collected at 21 days of age for genotyping using polymerase chain reaction 
(PCR). As TLR4
-/-
 mice are viable without baseline abnormalities, we anticipated no baseline 
phenotypic variation in the mice with TLR4 deleted from specific cell types. Mice were 
randomly chosen for analyses. All procedures were carried out in accordance with regulations 
regarding for the care and use of experimental animals published by the National Institutes of 
Health and was approved by University of Pittsburgh Institutional Animal Use and Care 
Committee. 
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4.2.2 Surgical Procedure 
Mice (WT, TLR4
-/-
, Lyz-TLR4
-/-
, and TLR4
loxp/loxp
) were anesthetized with isoflurane (4% by 
inhalation) and 1.8 mm diameter defects were created on mouse parietal bones as previously 
described 
78
. 1 mg/kg ketoprofen (Fort Dodge Animal Health, Fort Dodge, IA) was administered 
as an analgesic immediately and for two days after surgery. All mice were euthanized via CO2 
overdose followed by cervical dislocation at designated time points. TLR4
-/-
 mice and Lyz-
TLR4
-/-
 mice were designated experimental groups and WT and TLR4
flox/flox
 mice were 
designated control groups. 
4.2.3 CT Analyses 
An average of ten mice from each group (WT, TLR4
-/-
, Lyz-TLR4
-/-
, and TLR4
loxp/loxp
) were 
euthanized at seven and 28 days after surgery. The skulls were dissected and stored in 4% 
paraformaldehyde overnight and later stored in 70% ethanol. The calvarial defect healing process 
was analyzed in three-dimensions (3D) using a high-resolution CT system with a fixed 
isotropic voxel size of 15 m. 3D images were reconstructed using Amira software (FEI 
Visualization Sciences Group, Burlington, MA) and OsiriX software. Quantitative data was 
analyzed by OsiriX software with a global fixed threshold -330 and a region of interest (ROI of 
0.4mm
220.9 mm) was defined. Standard CT measurements (regenerated bone volume (BV) = 
BV within the ROI at day 7, and 28– BV at day 0) were calculated for each sample using OsiriX 
software. 
 66 
4.2.4 Histology and Histomorphometric Analyses 
An average of four mice from each group (WT, TLR4
-/-
, and Lyz-TLR4
-/-
) were euthanized at 
day 0 and postoperative days one, four, seven, and 28. Calvariae and surrounding soft tissues 
(e.g., skin, brain) were harvested and fixed in 4% paraformaldehyde for 24 hours. Samples were 
decalcified in 10% EDTA prior to being dehydrated through a series of ethanol and embedded in 
paraffin.
78
 Paraffin-embedded specimens were sectioned through the coronal plane at a thickness 
of 5-6 µm. Slides were stained with Harris’ hematoxylin & eosin (H&E, Surgipath Medical 
Industries, Richmond, IL) for conventional, qualitative bright-field light microscopy.  
Russell-Movat pentachrome staining (American MasterTech, CA) was performed to 
further differentiate the following tissues within the defect: hematoma/fibrin (intense red), elastic 
fibers (black), newly-formed woven bone (yellow), and lamellar bone (red).  
Tartrate-resistant acid phosphatase (TRAP) stain: Sectioned slides were first incubated in 
phosphate buffered saline (pH=5) at 37C for five minutes, then incubated in TRAP buffer 
(PH=5), containing 0.1 M acetate buffer, 0.3 M sodium tartrate, 10 mg/ml Naphthol AS-MX 
phosphate, 100 μl Triton X-100, and 0.3 mg/ml Fast Red Violet LB salt for one hour at 37°C. 
Sections were counterstained with 0.02% fast green (Sigma-Aldrich Corp, St. Louis, MO) before 
mounting in cytoseal
TM
280 (Fisher Scientific, Pittsburgh, PA). Osteoclasts were detected as 
TRAP-positive cells.  
Histomorphometric analyses were performed to quantify cellular infiltration and two-
dimensional areas of new bone formation using a Leica MZ12 microscope (Leica Microsystems 
Ltd. Switzerland) and Northern Eclipse (v5.0) image analysis software (Empix, Imaging, Inc. 
Cheektowage, NY). Bone healing data was calculated based on three to five slides per animal. 
New areas of bone formation were visually identified under 100X magnifications. New bone 
 67 
area was calculated as the sum of the areas of each bone section, including within the defect and 
on both sides of the calvaria. The sum totals of newly formed bone areas were averaged by the 
number of slides per animal. Osteoblasts were calculated as the total number of osteoblasts per 
osteoblast-lining bone surface under 100X magnification. Osteoclasts were calculated as the total 
number of osteoclasts per field under 200X magnification. Data was expressed as mean +/- SEM. 
All measurements were taken by researchers blinded to group identity.  
4.2.5 Immunohistochemistry Analyses 
Sections from WT, TLR4
-/-
, and Lyz-TLR4
-/-
 mice were deparaffinized with xylenes and 
rehydrated through a series of ethanol to distilled H2O. Antigen retrieval was performed on all 
samples using a Universal Antigen Retrieval Kit (R&D Systems, Minneapolis, MN). Following 
the manufacturer’s instructions, sections were incubated in 10% blocking serum for one hour at 
room temperature. Sections were then incubated in primary antibodies, which were suspended at 
a 1:100~1:250 dilution in 10% blocking serum overnight at 4C. Sections were incubated in 
HRP-conjugated secondary antibody (dilution 1:100~1:250) for 30 minutes at room temperature. 
Color was developed by application of DAB kit (Vector Laboratories, Burlingame, CA). Horse 
and goat blocking serum came from Vector Laboratories. (Burlingame, CA). Primary antibodies 
were anti-OPN as a marker of osteogenic differentiation, anti-F4/80 as a marker for M0 
macrophages, and anti-Arginase1 as a marker for M2 macrophages (Santa Cruz Biotechnology, 
Santa Cruz, CA; Abcam, Cambridge, MA). Secondary antibodies were anti-goat horse IgG or 
anti-rabbit goat IgG (Vector Laboratories, Inc. CA). Sections were dehydrated and mounted prior 
to examination at 25X, 50X, 100X, 200X, and 400X magnifications.  
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4.2.6 mRNA Extraction and Expression Analyses 
An average of five mice from each group (WT, TLR4
-/-
, and Lyz-TLR4
-/-
) were euthanized at 
day 0 before surgery and at three hours on days 1 and 4 after surgery. Samples surrounding the 
initial 1.8 mm defect were collected using a 5.0mm outer diameter trephine (Fine Science Tools, 
Foster City, CA), including blood clots, hematoma, granulation tissue, new bones, and 
surrounding normal bones. Samples were stored at 4°C in RNAlater solutions (Life 
Technologies, NY) until ready for RNA isolation. The specimens were homogenized and RNA 
was extracted from the sample using RNAqueous-Micro Kit (Life technologies, NY) according 
to the manufacturer’s protocol. Primers used in the study recognized IL-1, IL-6, IL-4, IL-10, 
BMP-2, TGF-1, Runx2, Osterix, RANKL, OPG, iNOS, Arginase, and TLR2. The 
housekeeping gene GAPDH was chosen as an internal control. RT-PCR results were calculated 
by standard curve analysis. The relative amount of target gene was normalized to the expression 
of neomycin resistance gene. Finally, relative fold change in expression of target gene to 
GAPDH in WT, TLR4
-/-
, and Lyz-TLR4
-/-
 mice was compared at designated time points.   
4.2.7 In Vitro Bone Marrow-derived Osteoclast Differentiation Assay 
Femora and tibiae were excised from seven- to 10-week-old female mice (WT, TLR4
-/-
, and 
Lyz-TLR4
-/-
). The soft tissue and connective tissue were carefully removed and the ends of the 
bones were cut off.  Bone marrow was flushed out using a 5mL syringe into a 50mL tube with 
DMEM media (Life technology, NY). Bone marrow suspension was centrifuged at 1000 rpm, 
4 ̊C for five minutes. The supernatant was removed and the cells were suspended in the DMEM 
media containing 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, and 10ng/ml M-
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CSF. The cell suspension was seeded onto a 6-cm cell culture dish. Sixteen hours after seeding, 
unattached cells were collected and seeded with DMEM containing 10% FBS, 1% 
penicillin/streptomycin, and 30ng/ml M-CSF (Life Technologies, Carlsbad, CA) at 10
5
 
cells/well on a 24-well plate.  Three days after seeding, the media was changed to fresh DMEM 
containing 10% FBS, 1% penicillin/streptomycin, 30ng/ml M-CSF (Life Technologies, 
Carlsbad, CA), and 50ng/ml RANKL (Life Technologies, Carlsbad, CA). 
ALP and TRAP Staining: At day 5 and day 7 after osteoclast differentiation culture, 
cells were fixed with 10% buffered paraformaldehyde solution. Fixed cells were stained with 
TRAP and ALP double-stain kit (Takaba, Clontech Laboratories, CA) according to the 
manufacturer’s protocol. After staining, TRAP-positive cells and ALP-positive cells were 
quantified under 100X magnification. 
4.2.8 Statistical Analyses 
Statistical analyses were performed using SPSS v.20.0 software (SPSS, Inc, Chicago, IL). Data 
(Mean BV calculation from CT analyses, mean areas of newly-formed bone, N.Ob/BS and 
N.Oc/BA collected from histomorphometric measurements and numbers of ALP (+) and TRAP 
(+) cells from in vitro cultures) were compared using one-way ANOVA followed by post-hoc 
LSD test. A p value less than or equal to 0.05 was considered significant. 
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4.3 RESULTS 
4.3.1 Accelerated Intramembranous Bone Formation in TLR4-/- and Lyz-TLR4-/- Mice 
In order to characterize the bone healing process, µCT was performed on four groups of mice 
(WT, TLR4
-/-
, Lyz-TLR4
-/-
 and TLR4
loxp/loxp
 at postoperative days 7 and 28. Representative 3D 
reconstructed images are shown in Fig.13. No group showed complete bone healing within 28 
days of observation. Areas of mineralized tissue were observed in TLR4
-/-
 and Lyz-TLR4
-/-
 mice, 
while no obvious new bone formation was evident in WT and TLR4
loxp/loxp
 mice at day7 (Fig. 
13A). Significantly larger BV was found in TLR4
-/-
 and Lyz-TLR4
-/-
 mice compared to WT mice 
on day 7  (Fig. 13B). No significant difference in bone healing based on µCT was found between 
WT and TLR4
loxp/loxp
 mice at all time points.  
 
Figure 13: µCT analyses 
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(A) Representative 3D reconstructions of calvarial defects in the transverse plane at postoperative days 0, 7, and 28 
of WT, TLR4
-/-
, and Lyz-TLR4
-/-
 mice. Faster healing was evident in TLR4
-/-
 and Lyz-TLR4
-/-
 mice, as indicated by 
more mineralized tissue around the defect edges at day 7 (arrows). Similar bone healing was shown among the three 
groups on day 28. (B) Statistical analyses of bone volume (BV) measurements at different time points. Significantly 
larger BV was found in TLR4
-/-
 and Lyz-TLR4
-/-
 mice relative to WT mice at day 7, while no significant differences 
were seen among the three groups at day 28. No significant difference in BV between TLR4
-/-
 and Lyz-TLR4
-/-
 mice 
was seen at both days 7 and 28. (Scale: 500 m, p<0.05, * compared to WT mice).   
 
To further demonstrate the accelerated healing response in TLR4
-/-
 and Lyz-TLR4
-/-
 mice, 
H&E staining, pentachrome staining, and IHC staining for osteopontin (OPN) were performed. 
Histological healing patterns at day 7 demonstrated larger areas of newly-formed woven bone at 
the endocortical side of cavalria bone in TLR4
-/-
 and Lyz-TLR4
-/-
 mice compared to WT mice, 
accompanied by active osteoblast infiltration, and enhanced OPN staining (Fig. 14A and 
Fig.15A). On day 28, similar histological characteristics were seen among the three groups. 
Although woven bone matrix was still evident, mature lamellar bone was present on the 
ectocortical and endocortical calvarial sides in all groups on day 28 (Fig. 14B). 
Histomorphometric measurements showed significantly larger areas of newly-formed bone and 
significantly more infiltrated osteblasts in the TLR4
-/-
 and Lyz-TLR4
-/-
 mice compared to WT 
mice at day7 (Fig. 14C and Fig. 15B). No significant difference in new bone areas or osteoblast 
numbers was found between TLR4
-/-
 and Lyz-TLR4
-/-
 mice on day7 (Fig. 14C and Fig. 15B) and 
among the three groups on day 28 (Fig. 14D).  
Levels of osteogenic gene expression (BMP2, TGF-1, RUNX2, and Osterix) from WT, 
TLR4
-/-
, and Lyz-TLR4
-/-
 mice were compared at 0 hour, 3 hours, day 1, and day 4. No 
significant differences in expression levels were detected at zero hour (data not shown). Elevated 
expression of these four genes was observed in TLR4
-/-
 after surgery, while no significant change 
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in gene expression was observed in WT and Lyz-TLR4
-/-
 mice, (Fig.15C). BMP2 and TGF-1 
expression exhibited a significantly higher fold change in TLR4
-/-
 mice than in WT and Lyz-
TLR4
-/-
 mice at day 1 post surgery. No difference in expression level of RUNX2 and Osterix 
were observed among the three groups at all time points. 
  
Figure 14: Accelerated intramembranous bone formation in TLR4
-/-
 and Lyz-TLR4
-/-
 mice 
(A) Representative H&E-stained images at day 7. Disorganized loose connective tissue completely filled the bone 
defect on day 7 in all groups. Larger area of newly-formed cellularized woven bone was observed in TLR4
-/-
 mice 
and Lyz-TLR4
-/-
 mice compared to WT mice. (B) Similar histological healing pattern was observed in all groups and 
no groups showed complete bone healing at day 28. (C-D) One-way ANOVA showed significantly large areas of 
bone formation in TLR4
-/-
 and Lyz-TLR4
-/-
 mice compared to WT mice. No significant difference was detected in 
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bone formation among three groups on day 28. (Scale bar: 50 m; bolded arrow: defect margin; Ob: osteoblast; Wo; 
woven bone; LB: lamellar bone; p<0.05, * vs. WT). 
 
 
 
Figure 15 : Enhanced osteogenesis in TLR4
-/-
 and Lyz-TLR4
-/-
 mice 
 (A) Representative pentachrome-stained and anti-OPN-stained images. One or two layers of bone surface-lining 
osteoblasts were observed on the endocortical side of calvarial bone in WT mice. More infiltrated osteoblasts, larger 
areas of newly-formed woven bone matrix (yellow in pentachrome staining), and more intense OPN staining were 
evident in both TLR4
-/-
 and Lyz-TLR4
-/-
 mice than in WT mice. (B) One-way ANOVA showed significantly more 
osteoblasts in TLR4
-/-
 and Lyz-TLR4
-/-
 mice compared to WT mice. (C) Elevated expression of BMP2, TGF-1, 
RUNX2, and Osterix were evident in TLR4
-/-
 mice after surgery, while remaining relatively unchanged in WT mice. 
Significantly higher fold change in expressions of BMP2 and TGF-1 were observed in TLR4-/- mice than in WT 
and Lyz-TLR4
-/-
 mice at day 1. No significant differences in expressions of RUNX2 and Osterix were found among 
the three groups at all time points. (Scale bar: 50 m; bolded arrow: defect margin; Ob: osteoblast; Wo; woven 
bone; Endo: endocortical side; p<0.05, * vs. WT, # vs. Lyz). 
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4.3.2 TLR4 Inactivation Enhanced Osteoclastogenesis In Vitro and In Vivo 
In order to gain better understanding of osteoclast infiltration and tissue resorption during the 
early phase of the fracture healing process, TRAP staining of paraffin-embedded slides of WT, 
TLR4
-/-
, and Lyz-TLR4
-/-
 mice was performed on day 7. TRAP (+) osteoclasts were evident at 
the defect margin and newly-regenerated woven bone in all groups at day 7 (Fig. 16A). More 
intense TRAP (+) staining and significantly more osteoclasts were detected in Lyz-TLR4
-/-
 mice 
relative to WT mice (Fig. 16A and Fig.16B). The number of osteoclasts did not significantly 
differ between TLR4
-/-
 mice and Lyz-TLR4
-/-
 mice at day 7 (Fig. 16B).  
Levels of osteoclastogenic gene expression (RANKL and OPG) from WT, TLR4
-/-
, and 
Lyz-TLR4
-/-
 mice were compared at 0 hour, 3 hours, day 1 and day 4. No significant differences 
in expression levels were detected at 0 hour (data not shown). WT mice did not exhibit obvious 
changes in expression of RANKL or OPG, while TLR4
-/-
 and Lyz-TLR4
-/-
 mice both showed 
increased expression of RANKL and OPG after surgery (Fig. 16C-16D). A significantly higher 
expression of RANKL was found in TLR4
-/-
 mice compared to WT mice at day 4, and a higher 
expression of OPG was found in TLR4
-/-
 mice compared to WT mice at day 1. No significant 
difference in expression level of RANKL and OPG was detected between TLR4
-/-
 and Lyz-
TLR4
-/-
 mice at all time points (Fig. 16C-16D). 
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Figure 16: Enhanced osteoclastogenesis in TLR4-deficient mice 
(A) Representative TRAP-stained images at day 7. TRAP (+) osteoclasts were evident at the defect margin and the 
bone marrow space. More intense TRAP (+) staining was shown in Lyz-TLR4
-/-
 mice compared to WT mice. This 
observation was consistent with TRAP (+) osteoclast counts shown in (B). No significant difference in numbers of 
TRAP(+) osteoclast was shown between TLR4
-/-
 mice and Lyz-TLR4
-/-
 mice at day 7. (C) Similar expression 
patterns of RANKL and OPG were shown between TLR4
-/-
 and Lyz-TLR4
-/-
 mice, while fold change in expression 
of these two genes remained relatively unchanged in WT mice after surgery. No differences were found in 
expression levels of RANKL or OPG between TLR4
-/-
 and Lyz-TLR4
-/-
. (Scale: 50 m; bolded arrow: defect 
margin; Endo: endocortical side; p<0.05, * compared to WT mice). 
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To better understand the capacity of osteoclast differentiation and resorption activity of 
WT, TLR4
-/-
, and Lyz-TLR4
-/-
 mice, TRAP and ALP double staining was performed on the bone 
marrow-derived primary cells obtained from the three groups. More red, TRAP (+), cells were 
observed in the TLR4
-/- 
culture group on both day 5 and day 7 compared to the WT and Lyz-
TLR4
-/- 
groups. Similar ALP-positive staining was observed among the three groups at both time 
points (Fig. 17A-17C). Consistent with observations from in vitro staining, significantly more 
TRAP (+) cells were seen in the TLR4
-/-
 group compared to the WT and Lyz-TLR4
-/-
 groups on 
both day 5 and day 7. No significant differences in ALP (+) cell numbers were seen among all 
three groups (Fig. 17B). 
 
Figure 17 in vitro osteoclast differentiation analysis 
(A) Representative TRAP-stained images at day 5 and day 7. More TRAP (+) cells were observed in TLR4
-/-
 mice 
compared to the other two groups. This observation was consistent with TRAP (+) osteoclast counts shown in (B). 
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(C) Comparable ALP (+) cells were shown among all three groups. (D) TLR4 expression was not detected in TLR4
-
/-
 culture group.  
4.3.3 Inflammatory Response  during the Healing Process in the Absence of TLR4 
In order to better understand the inflammatory response during early fracture healing, anti-F4/80 
and anti-Arginase1 IHC staining and inflammatory cytokine expression (IL-1, IL-6, IL-4, IL-
10, iNOS, Arginase, and TLR2) were analyzed. At day 1, similar intense staining of anti-F4/80 
indicating infiltration of M0 macrophages, and anti-Arginase1 staining indicating M2 
macrophages were evident in all groups (Fig. 18A). At days 4 and 7, no obvious anti-F4/80 or 
anti-Arginase1 positive staining was observed in all groups (data not shown). Inflammatory gene 
expression from WT, TLR4
-/-
, and Lyz-TLR4
-/-
 mice was detected at 0 hour, 3 hour, day 1 and 
day 4 (Fig. 18B). No significant differences in expression levels were detected at 0 hour (data not 
shown). TLR4
-/-
 mice exhibit significantly higher expression of IL-1 at day 1, and significantly 
higher expression of TLR2 at 3h and day 1 compared to WT and Lyz-TLR4
-/-
 mice (Fig. 18B). 
IL-6 presented the highest expression levels at three hours, and declined in expression at later 
time points in all groups (Fig. 18B). No difference in expression level of iNOS and arginase was 
detected among all groups (Fig. 18B). Neither IL-4 nor IL-10 expression were detected at all 
time points (Data not shown) 
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Figure 18: Unshifted balance of inflammatory response in TLR4-deficient mice 
(A) Representative anti-F4/80 and anti-Arginase1 stained images at day 1. Similar anti-F4/80 staining and anti-
Arginase1 staining, suggesting M0 and M2 macrophage infiltration, was observed in WT, TLR4
-/-
, and Lyz-TLR4
-/-
 
mice at day 1. (B) Fold change in expression of inflammatory cytokines from WT, TLR4
-/-
, and Lyz-TLR4
-/-
 mice at 
three hours, day 1 and day 4. Significantly higher expression of IL- was detected in TLR4-/- mice compared to WT 
and Lyz-TLR4
-/-
 mice at day 1. Significantly higher expression of IL-6 was shown in Lyz-TLR4
-/-
 mice compared to 
WT mice at day 4. Significantly higher expression of TLR2 was observed in TLR4
-/-
 mice compared to Lyz-TLR4-/- 
and WT mice at day 1 and day 4. No significant difference was found in expression levels of iNOS and Arginase in 
all groups. Neither IL-4 nor IL-10 expression was detected at all time points. (Scale: 50 m; bolded arrow: defect 
margin; Endo: endocortical side; ND: not detected; p<0.05, *compared to WT mice, # compared to Lyz-TLR4
-/-
 
mice). 
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4.4 DISCUSSION 
The aim of this study was to investigate the effect of TLR4 depletion on 
osteoclastogenesis and its impact on bone healing. We found that depletion of TLR4 from 
osteoclast precursors resulted in enhanced osteoclastogenesis and accelerated bone healing in a 
calvarial defect model, suggesting an important role of TLR4 in regulating osteoclastogenic 
differentiation. 
Since TLR4 has been reported to have a profound role in mediating innate immune 
response and skeletal tissue homeostasis, we aimed to test the effect of TLR4 deletion on both 
osteoclastogenesis differentiation and macrophage polarization in this study. Previous studies 
have used the cathepsin K (Ctsk) or Tartrate-resistant acid phosphatase (TRAP) promotors, which 
are expressed in mature osteoclasts or osteoclast precursors and osteoclasts respectively, to 
generate osteoclast-specific KO animal model 
175
. However these two osteoclast-specific animal 
models do not target macrophage lineage differentiation. As lysozyme is predominantly 
synthesized in myelomonocytic lineage 
176
, we utilized a calvarial defect model of myeloid 
lineage-specific TLR4
-/-
 mice (Lyz-TLR4
-/-
 mice), in which Cre under lysozyme (lyz) promoter 
enables inducible recombinase expression in osteoclast and macrophage precursors, in order to 
test the early development and differentiation of osteoclast/macrophage after calvarial fracture.  
Consistent with our hypothesis, accelerated bone healing and increased infiltration of 
osteoclasts were observed in Lyz-TLR4
-/-
 and TLR4
-/-
 mice. Although the differences in RANKL 
expression observed between Lyz-TLR4
-/-
 and WT mice were not statistically significant, the 
increased RANKL expression pattern for Lyz-TLR4
-/-
 mice was similar to TLR4
-/-
 mice, while 
RANKL expression remained relatively unchanged in WT mice after surgery. Previous studies 
showed that enhanced osteoclast activity is the main driving force for chronic inflammation-
 80 
stimulated bone destruction
101,102,171,172,173
, however, in our non-compromised calvarial defect 
model it initiates an earlier bone repair cascade. Collectively, these data suggest that TLRs may 
act as a “switch,” directing precursors towards differentiation into either inflammatory cells or 
bone-resorbing osteoclasts. This regulatory role of TLR4 in osteoclastogenesis might be due to 
the fact that TLR4 can signal through two adaptor proteins, MyD88 and TRIF. This unique 
property of TLR4 has also been reported in other animal models. For example, TLR4 signaling 
through the MyD88-dependent pathway contributes to ischemic brain damage 
125-127
, whereas 
TRIF-mediated signaling exerts a neuroprotective effect against cerebral ischemia 
129
. Thus, the 
functional consequences of TLR4 activation on tissue regeneration might depend upon its 
activation through different signaling pathways. In addition, studies have also suggested that 
TLR activation in osteoclast precursors maintains their phagocytic activity and inhibits their 
differentiation into non-inflammatory mature osteoclasts, whereas TLR activation on mature 
osteoclasts increases their survival rate 
167
. In light of these findings, TLR4 may be involved in 
regulating the balance between immune response and bone metabolism at different stages of 
differentiation by utilizing different down stream pathways.  
Although TLR4
-/-
 mice and Lyz-TLR4
-/-
 mice present similar healing phenotypes, the 
mechanisms through which this occurs may be different. Despite similar accelerated bone 
healing observed in both TLR4
-/-
 and Lyz-TLR4
-/-
 mice, higher expression of osteogenic genes 
(BMP-2 and TGF-1) and inflammatory cytokine (IL-1) were only observed in TLR4-/- mice. 
Thus, enhanced osteogenesis and inflammatory cytokine expression might also contribute to the 
accelerated healing observed in TLR4
-/-
 mice. Traditionally, inflammation has often been 
negatively associated with pathological bone destruction. However, in recent years, there has 
been an increased interest in elucidating the positive role of inflammation in bone regeneration 
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and repair. The impact of inflammation on healing is complex, however, and may be either 
beneficial or detrimental to repair.
75,76,177
 In general, key inflammatory molecules, such as IL-1, 
IL-6 and TNF-, have well-established roles in modulating the proliferation and differentiation 
of skeletal cells during the fracture healing process 
74
. Specifically, IL-1 has been shown to 
present high expression levels during the osteogenic phases of fracture repair, suggesting its 
involvement in promoting osteoblast proliferation and differentiation 
178
. In addition, 
administration of IL-1 lead to increased cartilage to callus formation at early time points after 
long bone fracture, while mice lacking IL-1 did not exhibit obvious changes in long bone 
fracture healing 
113
. These observations were in agreement with our findings showing that 
increased IL-1 expression was associated with accelerated bone healing observed in TLR4-/- 
mice. 
In addition, TLRs can act reciprocally to compensate for each other's loss of gene 
function 
134,135,145,146
 which is consistent with our results showing higher TLR2 expression in 
TLR4
-/-
 mice compared to WT mice and Lyz-TLR4
-/-
 mice at all time points. Similar to TLR4, 
TLR2 can recognize signals from both bacterial infection and tissue damage. Studies have shown 
a role for TLR2 in pathogen-associated bone destruction and impaired wound healing 
144,179,180
. 
In addition, it is implicated that TLR2 activation is essential for recruiting neutrophils following 
injury 
181
, and neutrophils, which infiltrate into fracture hematoma, produce several macrophage 
chemoattactants, triggering macrophage infiltration 
182,183
. However, there are no studies that 
show a direct influence for TLR2 with regards to fracture healing. Whether up-regulated TLR2 
expression is partially responsible for the faster healing phenotype observed in TLR4
-/-
 mice 
requires further studies.  
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Macrophages are highly involved in regulating inflammation, and also play an integral 
role in tissue regeneration. Within the first 3 days of injury, macrophages infiltrate into the 
wound bed, participating in the inflammatory response and debridement process via 
phagocytosis activity and reactive radical release. Lee et al. showed that macrophage activation 
and polarization influence kidney injury and repair 
184
. Depletion of M1 macrophages decreased 
kidney damage whereas depletion of M2 macrophages increased kidney damage 
184
. Macrophage 
polarization is known to be associated with TLR signaling in acute kidney injury. By deleting a 
macrophage-specific inhibitor of TLR signaling known as IL-1 receptor-associated kinase-M, 
polarization towards an anti-inflammatory M2 phenotype is prevented, resulting in up to two-
thirds loss of kidney mass and interstitial scarring 
185
. Since macrophages are derived from 
myeloid cells, we examined their differentiation and polarization after the calvarial defect in 
Lyz-TLR4
-/-
 mice. We observed similar infiltration levels of M0 and M2 macrophages in WT, 
TLR4
-/-
 and Lyz-TLR4
-/-
 mice at day 1, consistent with the expression levels of iNOS, which is 
expressed by M1 macrophage, and expression level of arginase, which is expressed by M2 
macrophage, based on RT-PCR results. Together, depletion of TLR4 expression in myeloid cells 
did not seem to change macrophage-lineage differentiation or macrophage polarization in this 
calvarial defect model. However, more evidence related to the differentiation and phagocytic 
activity of macrophages is needed in order to gain a better understanding of the impact of TLR4 
depletion in myeloid cells on macrophage differentiation and inflammatory reaction. 
Taken together, our data suggest that TLR4 depletion in myeloid cells enhanced 
osteoclastogenesis and infiltration into the injury site, resulting in accelerated bone healing in a 
non-compromised calvarial defect model. Our study shows that TLR4 signaling plays an 
important regulatory role in enhancing bone destruction and initiating early bone healing via 
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control of osteoclastogenesis in myeloid cells. This highlights a potential opportunity in which 
appropriate modulation of the TLR4 signaling pathway can be used to reduce bone destruction in 
inflammatory bone diseases or enhance early healing in bone defects to improve clinical 
outcomes. 
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5.0  TOLL-LIKE RECEPTOR 4 MEDIATES THE REGENERATIVE EFFECTS OF BONE 
GRAFTS FOR CALVARIAL BONE REPAIR 
5.1 INTRODUCTION 
Large bone defects are notoriously difficult to repair, presenting a significant risk to patients and 
an enormous challenge to reconstructive surgeons. Autologous and allogeneic bone remains the 
graft materials of choice for surgical reconstruction of large bone defects owing to their clinical 
efficacy and minimal side effects. A clinical demand for bone graft substitutes exists, however, 
due to the limited availability of donor material. Commercial bone graft substitutes are available 
within the clinical setting, but are generally considered to possess inferior osteoconductive, 
osteoinductive, and osteogenic properties when compared to autologous or allogeneic graft 
186
.
 
A 
better undertanding of the biological basis for the superiority of bone graft in promoting tissue 
repair is needed to improve the design of graft substitutes for the repair of large bone defects.  
Autologous bone graft consists of cellular and matrix components which are presumed to 
facilitate integration with host tissue following transplantation. The cellular component of 
autologous bone is associated with its superior osteogenic properties and includes osteoblasts, 
osteoclasts, osteocytes, and supporting stromal cells. The acellular component of bone is derived 
primarily from the bone extra-cellular matrix (ECM) and its associated biochemical cues which 
include growth factors and other signaling molecules secreted by bone cells. The acellular 
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component of bone has osteoconductive and osteoinductive properties, providing architectural 
support and creating a distinct biochemical environment that supports the formation and 
maintenance of bone 
187,188
. The cellular and acellular components of bone graft possess 
immunologic properties which are incompletely understood 
94,189
. Recent studies have 
demonstrated that a potent inflammatory response to damaged ECM and necrotic or stressed 
cellular components is also involved in tissue regeneration, highlighting a potential role for graft-
induced inflammation in facilitating fracture healing 
190,191
. Although considerable controversy 
exists regarding the exact role of inflammation during bone healing, inflammation is well 
recognized as an integral component of the injury response and has received increasing attention 
for its role in host tissue regeneration and repair 
75,76
. The inflammatory response following bone 
injury is critical for the initiation of healing cascades, serving to recruit inflammatory and 
progenitor cells and to promote angiogenesis during the remodeling of damaged tissues 
93
. A role 
for inflammation in graft-induced bone regeneration has been suggested, but is still not well 
understood.  
Toll-like receptors (TLRs) play an essential role in innate recognition of microbial 
products and are critical activators of the innate immune response. Another unique role of TLRs 
is to sense cellular stress or tissue damage by responding to endogenous ligands released from 
necrotic cells and damaged tissues in many settings including musculoskeletal trauma 
75,172
. TLR 
expression is primarily detected within macrophages, neutrophils, dendritic cells, and bone cells 
159,177,192,193
. TLR4 signaling is of particular interest in regenerative biology due to its pronounced 
impact on healing in diverse models of injury and sterile inflammatory disease 
159,160
. The impact 
of TLR4 activation on tissue homeostasis and regeneration partially depends upon organ setting 
and mode of injury. TLR4 signaling has been suggested to mediate bone destruction by inducing 
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inflammation and osteoclastogenesis 
168,194-196
. In a previous study, we showed that calvarial 
bone healing is accelerated in TLR4 knock-out (TLR4
-/-
) mice and is associated with elevated 
expression of cytokines and osteoclast differentiation markers 
78
. Furthermore, our team has 
previously presented data suggesting that morselized bone graft induces a TLR4-dependent 
systemic inflammatory response in a bilateral femoral fracture model 
104
. Based upon these 
observations, we hypothesized that TLR4 signaling is necessary for graft-induced bone 
formation by mediating the remodeling and integration of bone graft within regenerating 
calvarial defects. To test this hypothesis, we assessed calvarial bone healing using radiography, 
live computerized tomography, and histological analyses in WT and TLR4
-/-
 mice engrafted with 
different fractions of morselized bone-enriched implants.        
5.2 MATERIALS AND METHODS 
5.2.1 Animal Care and Experimental Design 
Wild type (WT) C57BL-6J mice (Jackson, Bar Harbor, ME) and TLR4
-/-
 mice (from an ongoing 
breeding colony housed at the University of Pittsburgh), between 10 and 12 weeks of age (20-30 
g) were utilized in this study. All mice were maintained in the Rangos Research Center Animal 
Facility, Children’s Hospital of University of Pittsburgh with a 12:12 h light-dark cycle and free 
access to standard laboratory food and water. All procedures were carried out in accordance with 
the regulations regarding the care and use of experimental animals published by the National 
Institutes of Health and was approved by the Institutional Animal Use and Care Committee of 
the University of Pittsburgh. 
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5.2.2 Preparation of Bone Component Implants 
In the current study, four different types of implants derived from morselized bone and PBS 
solution were implanted into the WT and TLR4
-/-
 mice. The four implants included (1) “BC” 
group (morselized bone components), (2) “BC+TLR4 inhibitor” group and “BC+TLR4 inhibitor 
peptide control” group (morselized bone component mixing with TLR4 peptide inhibitor, or with 
its peptide control), (3) “CE” group (fractionated, cell-enriched portion of morselized bone 
component), and (4) “ME” group (fractionated, matrix-enriched portion of morselized bone 
component).  
To generate implants, two femora and two tibiae were harvested from one donor WT 
mouse and were crushed with a mortar and pestle under sterile conditions, while bone marrow 
was not removed prior to crushing. The “BC” group was generated by resuspending the 
morselized bone in 1 mL of PBS.  The “BC+TLR4 inhibitor” group was generated by 
resuspending the morselized bone in 1 mL of VIPER TLR4 neutralizing peptide (0.3mg/ml, 
IMGENEX, CA). To fractionate the “BC” group into its “CE” and “ME” groups, morselized 
bone resuspended in 1 mL of PBS was flushed through a 70-µm cell strainer (BD Biosciences, 
Bedford) and centrifuged at 1,200 rpm for 10 min. The resulting cellular pellets were 
resuspended in 1 mL of PBS to obtain the “CE” group. The remaining bone cortices were 
resuspended in 1 mL of PBS to derive the “ME” group. Cell counts of the “CE” group per 
animal showed approximately 6 to 8 × 10
5
 nucleated cells per mL. The density of “ME” group 
was 200 to 300 mg/mL. Fractionated bone suspensions (300 L) were mixed with 100 µL 
fibrinogen (10mg/mL) and 2 µL thrombin (Sigma-Aldrich, MO) and were incubated at 37C for 
one hour before being implanted in the calvarial defect model. (Fig. 19) Sham controls received 
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no graft following surgery and vehicle controls were prepared in the absence of bone 
components. 
 
Figure 19: Preparation of bone component implants 
(A) Morselized bone (BC), cell-enriched fraction of morselized bone (CE), and matrix-enriched fraction of 
morselized bone (ME) suspension preparation. (B) Fractionated bone suspensions (300 L/each group) were mixed 
with fibrinogen and thrombin, and were incubated at 37C for one hour before being implanted in the calvarial 
defect model. 
 
As bone marrow was not removed prior to crushing the donor bones, CE suspension was 
considered to be rich in bone marrow lineage cells including hematopoietic cells, myelopoietic 
cells, erythropoietic cells, and mesenchymal stem cells; while ME suspension included 
mesenchymal stem cells, bone-, adipose-, muscle- residency cells 
197-200
. To further characterize 
the CE and ME suspension, Syto® green-fluorescent nucleic acid staining (Life Technologies, 
 89 
NY), Propidium Iodide staining (PI staining, Sigma-Aldrich, MO), PicoGreen® dsDNA Reagent 
and Kits (Life Technologies, NY), Near-infrared fluorescent probe image system (far-red 
fluorescent pamidronate, FRFP680, Osteosence, VisEn Medical, Bedford, MA) were applied 
according to manufacturer’s instructions.  
CE and ME suspension from three donor WT mice was separately diluted with PBS to 1 
million cell per mL, and washed with sterilized PBS three times prior to following staining. 
Suspension was incubated with 5 µM Syto® green dye and 3 µM PI dye in dark at 37̊C for half 
an hour before observed under fluorescent microscopy. All specimens were imaged at 100X and 
200X magnifications. FRFP680 is a fluorescently-labeled bisphosphanate that binds to mineral 
substrates, and has been utilized as a tool for monitoring bone remodeling and skeletal 
calcification in vivo 
201
. To demonstrate the extent of matrix portion in CE and ME portion, three 
WT mice, between 10 and 12 weeks of age, were administrated FRFP680 at 10 nmol/100 µL by 
tail vein injection. Baseline tissue autofluorescence was examined in two WT mice with control 
saline injection. Mice were euthanized at twenty-four hours after FRFP680 administration. 
Femora and tibiae were harvested and imaged by IVIS imaging system (IVIS
®
 lumina, Xenogen, 
Cranbury. NJ). CE and ME suspension were later collected as previously described and imaged 
by IVIS imaging system for fluorescence efficiency. To characterize the extent of dsDNA 
concentration in CE and ME portion, CE and ME solution from three donor mice were 
suspended in TE buffer and stained with PicoGreen® dsDNA reagent at room temperature in 
dark for 10 minutes. Fluorescence intensity was later measured using Synergy H1 Hybrid 
microplate reader  (BioTek, Winooski, VT).  
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5.2.3 Calvarial Defect Model 
A circular parietal defect was made using a 1.8 mm outer diameter trephine (Fine Science Tools, 
Foster City, CA) as previously described 
78
 to model craniofacial bone defects that result from 
trauma, craniofacial reconstruction, or management of tumors. Implants were created using a 5 
mm outer diameter trephine (Fine Science Tools, Foster City, CA). Circular implants in the 
groups outlined above were placed on top of the 1.8mm calvarial defect. After implant 
placement, the scalp was closed with 4-0 Vicryl resorbable sutures. During surgery, sterile PBS 
was used for continuous irrigation at the defect site and 1 mg/kg ketoprofen (Fort Dodge Animal 
Health, Fort Dodge, IA) was administered immediately post-surgery as an analgesic.  
5.2.4 Live Micro-computed Tomographic (CT) and Radiographic Analyses 
For characterization of three-dimensional (3D) calvarial defect healing process, bone healing was 
analyzed using a high-resolution CT system (Inveon microCT, Siemens, Germany). At 
postoperative days 0, 7, 14 and 28, “BC” implanted WT and TLR4-/- groups, and “BC+TLR4 
inhibitor” implanted WT group (average 7 each) were scanned using live CT with a fixed 
isotropic voxel size of 63.8 m. 3D images were reconstructed using Osirix software and region 
of interest (ROI) was defined as 4.0 mm
2  2.09 mm. Qualitative and quantitative data were 
analyzed by Osirix software with a global fixed threshold of -330.  Standard CT measurements 
(bone volume fraction, BV/TV within the ROI; regenerated BV: BV-day0 BV) were calculated 
for each sample using Osirix software. “CE” and “ME” implanted WT and TLR4-/- mice were 
also sacrificed on postoperative day 28. Calvariae were harvested and fixed in 4% 
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paraformaldehyde for 24 hours. Radiographs were obtained using Faxitron MX-20 (Faxitron X-
Ray, Lincolnshire, IL) with a 35 Kv exposure and a 45-second exposure time to analyze calvarial 
healing.  
5.2.5 Histological Analyses 
H&E and pentachrome staining was performed as described in our previous study 
78
. Calvarial 
samples obtained from each group were harvested, fixed in 4% paraformaldehyde, decalcified in 
EDTA, dehydrated in a series of graded ethanol (EtOH) solutions and subsequently embedded in 
paraffin. 5-6 µm thick sections were obtained from paraffin-embedded specimens by sectioning 
through the coronal plane. Three regions of each circular defect, 50 µm apart, were cut and 
placed on slides (for a total of approximately 30 slides per animal). Slides were stained with 
Harris’ hematoxylin & eosin (Surgipath Medical Industries, Richmond, IL) and Russell-movat 
pentachrome staining (American MasterTech, CA) for conventional, qualitative bright-field light 
microscopy. All specimens were imaged at 50X, 100X, 200X and 400X magnifications.  
Immunohistochemical staining was performed as previously described. 
78
 Sections were 
deparaffinized with xylene solution and rehydrated through serially graded ethanol (EtOH) 
solutions. Antibodies were diluted in in 2% normal horse serum (Vector Laboratories, 
Burlingame, CA) and incubated with sections according to the manufacturer’s instructions. 
Slides were incubated in goat polyclonal anti-F4/80 (Santa Cruz Biotechnology, Santa Cruz, CA; 
1:250 dilution), goat polyclonal anti-osteopontin (anti-OPN, Santa Cruz Biotechnology, Santa 
Cruz, CA; 1:250 dilution), and rabbit polyclonal anti-cathepsin K (Abcam, MA; 1:250 dilution) 
for 30 minutes at room temperature. Slides were then incubated in biotinylated horse anti-goat 
secondary antibody (BA-9500, Vector Laboratories, Inc. CA, USA; 1:250 dilution) or 
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biotinylated goat anti-rabbit secondary antibody (Abcam, MA; 1:250 dilution), followed by 
Streptavidin-HRP (R&D systems, Gaithersburg, MD; 1:500 dilution). Color was developed by 
application of DAB kit (Vector Laboratories, Burlingame, CA). Sections were dehydrated and 
mounted prior to examination at 50 X, 100 X, 200X and 400 X magnifications.  
Histomorphometric analysis was used to quantify two-dimensional bone formation using 
three to five slides per animal. New areas of bone formation were visually identified under 100X 
magnifications and measured using Northern Eclipse software (Empix Imagine, Inc., 
Mississauga, Ontario, Canada). Regions of new bone formation included areas at the defect as 
well as on both endo-and ecto-cranial surfaces of the calvaria within ROI. (Fig. 20) The sums 
total of newly formed bone areas were averaged by the number of slides per animal. 
 
Figure 20: Histomorphometric analysis method 
Microscopic images of the histological sections under 100X magnification were analyzed. (A) Representative 
images showed H&E stained slides at 100X magnification. Rectangle indicated ROI we used for histomorphometric 
analysis. The defect margin was identified (left vertical line). Since new bone formation occurred on both inside the 
defect as well as in the outside region surrounding the defect, a second margin was demarcated (right vertical line 
0.60 mm away from the defect margin). The distance for this second margin was chosen such that the majority of all 
new bone formation that occurs outside the defect margin was included for analysis. (B) New areas of bone 
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formation were identified by visual inspection up to the second margin (shown in color). This region excluded 
newly regenerated bone from the implanted graft. (Scale bar: 50 m; Ec: endocortical side) 
 
Anti-cathepsin K staining was used for visualizing the osteoclast infiltration.  Cathepsin 
K-positive cells attaching the bone surface were counted under 200X.  Numbers of osteoclasts 
per total bone surface area (N.OC/BS; n/mm) were calculated.  Data were expressed as mean 
area ± SEM. 
5.2.6 Statistical Analysis 
Statistical analyses were performed using SPSS v.20.0 software (SPSS, Inc, Chicago, IL). Mean 
areas of newly-formed bone by time points, numbers of osteoblasts per bone surface area, and 
numbers of osteoclasts per bone surface areawere compared among groups using One-way 
ANOVA followed by Post-hoc LSD test. A p value less than or equal to 0.05 was considered 
significant. 
5.3 RESULTS 
5.3.1 Characterization of BC, CE and ME Implants 
Characterization of CE and ME suspensions indicated good separation of grounded bone graft 
(BC group) into CE and ME portions (Fig.21). Both CE and ME suspensions contained similar 
percentages of live cells with around 44.5% live cells in CE suspension and 46.6% live cells in 
ME suspension. The CE suspension contained 22 million cells per mL while the ME suspension 
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contained 0.32 million cells per mL in the ME suspension (Fig.21A). IVIS imaging results 
showed that majority of FRFP fluorescent labeling was detected in the ME portion. Fluorescent 
efficiency in CE portion was similar compared to baseline control group without FRFP 
administration (Fig.21B). Picogreen® analysis demonstrated that there were average 38038.30  
817.95 ng/ml dsDNA in CE portion and average 5590.11  2114.96 ng/ml dsDNA in ME portion 
(Fig.21C).  
 
Figure 21: Characterization of implants 
(A) Live-dead cell analysis was characterized using Syto
®
green-fluorescent nucleic acid staining and Propidium 
Iodide staining. Quantitative analysis from stained images showed there was around 22 million cells (44.5% live 
cells) in CE solution and 0.32 million cells (46.6% live cells) in ME solution. (B) IVIS images showed FRFP 
fluorescent labeling in whole BC graft, CE and ME portion. IVIS images demonstrated a comparable fluorescent 
efficiency between BC graft and ME portion.  CE portion showed similar fluorescent efficiency to baseline control 
group without FRFP fluorescent reagent administration. (C) Picogreen
®
 staining kit was used to determine dsDNA 
concentration in CE and ME solution. Quantitative results showed that around 38038.30  817.95 ng/ml dsDNA in 
CE solution and 5590.11  2114.96 ng/ml dsDNA in ME solution.  
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5.3.2 Delayed Calvarial Healing in Absence of TLR4 Signaling after Bone Graft 
Implantation 
In order to understand the role of TLR4 signaling in bone graft-induced calvarial defect healing, 
BC (morselized bone component) implants, with and without a TLR4 inhibitor, were placed 
within calvarial defects of WT mice. BC was implanted in TLR4
-/-
 mice as well. Vehicle controls 
were included for both WT and TLR4
-/-
 mouse strains. Representative 3D reconstruction images 
of CT of three implant groups are shown (Fig. 22A). Qualitative and quantitative analyses of 
the calvarial defects revealed more mineralized tissue in the BC implanted WT group than either 
the BC implanted TLR4
-/-
 group or the BC+TLR4 inhibitor implanted WT group. Larger areas of 
mineralized tissue were visible within the defect and adjacent to the implants in the BC 
implanted WT group at designated time points compared to the other two groups. Morselized 
bone graft, however, remained relatively unchanged in TLR4
-/-
 mice or in WT mice when mixed 
with TLR4 inhibitor (Fig. 22A).  
Measurements from CT analysis revealed that bone volume fraction was significantly 
larger in the BC WT group (BV/TV: 28.46±6.88%) than in the BC TLR4
-/- 
group (BV/TV: 
17.15±1.47%, p<0.05) on day28. No significant difference in bone healing was observed 
between “BC+TLR4 inhibitor” WT group and BC TLR4-/- group on postoperative day 7, day 14 
or day 28 (Fig.22B). The BC WT group showed significantly larger volume of regenerated 
mineralized tissue compared to the WT vehicle control group at postoperative days 14 and 28. 
No significant differences in regenerated bone volume were observed between BC TLR4
-/-
, 
BC+TLR4 inhibitor WT and TLR4
-/-
 vehicle control groups (Fig. 22C). No significant difference 
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in bone volume fraction was observed between BC WT group and BC+TLR4 inhibitor control 
peptide group (Fig.23) 
 
Figure 22: Live CT analysis of WT and TLR4-/- graft recipients 
WT recipients were engrafted with BC in the presence or absence of TLR4 inhibitor, and TLR4
-/-
 recipients were 
engrafted with BC only. Calvarial bone repair was measured over 28 days using CT. (A) Representative 3D 
reconstructions of calvarial defects in the transverse plane at postoperative days 0, 7, 14 and 28. Each group received 
a similar amount of graft material at day 0. Faster healing was evident in BC implanted WT mice than the other two 
groups. (B) Quantitative data based on CT analysis revealed that bone volume fraction (BV/TV) in BC WT mice 
was larger relative to the other two groups. (C) More regenerated mineralized tissue was observed in the BC WT 
group than in the WT vehicle control group. Comparable healing was observed in the BC TLR4
-/-
, BC+TLR4 
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inhibitor WT, and TLR4
-/-
 vehicle control group on day 28. (BC: morselized bone components; scale bar: 500 µm; 
mean ± SEM; * p<0.05). 
 
Figure 23: CT analysis of WT and TLR4-/- graft recipients 
Quantitative data based on CT analysis revealed that bone volume fraction (BV/TV) in BC WT mice and 
“BC+TLR4 inhibitor peptide control” WT was larger relative to the other two groups. No significant differences 
were observed between “BC+TLR4 inhibitor” WT and BC TLR4-/-, and between BC WT mice and “BC+TLR4 
inhibitor peptide control” WT mice. (BC: morselized bone components; mean ± SEM; * p<0.05) 
 
 
 98 
5.3.3 Accelerated Intramembranous Bone Formation and Active Graft-remodeling in 
WT, but not in TLR4
-/-
 Mice after BC implantation 
Histological characterization revealed early evidence of intramembranous bone formation 
accompanied by greater osteoblast and macrophage infiltration and more intense periosteal and 
dural cellularity in WT mice compared to TLR4
-/-
 mice after BC implantation (Figs.24, and 
Fig.25). On day 7, BC WT mice exhibited more pronounced evidence of newly-formed, highly 
cellularized-woven bone along the endocortical (dural) side of the calvarial bone and along the 
defect perimeter than observed in control WT mice. Newly-regenerated woven bone was visible 
in the TLR4
-/-
 control group, while BC TLR4
-/-
 mice showed little-to-no obvious mineralization 
on day 7 (Fig.24A). Histomorphometric analysis on day 7 showed significantly more bone 
formation in the BC WT group compared to the WT sham control group and the BC TLR4
-/-
 
group, also WT control group compared to TLR4
-/-
 sham group. No significant difference was 
found between the BC TLR4
-/-
 group and the TLR4
-/-
 sham control group (Fig.24B). 
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Figure 24: Histology and histomorphometric analysis of calvarial bone repair in WT and TLR4
-/-
 graft 
recipients at post-operative day 7 
(A) Representative H&E stained images of WT or TLR4
-/-
 mice with and without BC implants on day 7. 
Cellularized woven bone formation was elevated in the BC WT group compared to the other three groups on day 7. 
(B) Histomorphometric analysis revealed more newly regenerated bone in BC WT mice compared to WT sham 
control and BC TLR4
-/-
 group, also TLR4
-/-
 sham group compared to WT control group. Comparable healing was 
observed in the BC TLR4
-/-
 group and TLR4
-/-
 sham control group on day 7. (Scale bar: 50 m; bolded arrow 
indicated defect margin; Ec: endocortical side; Wo: woven bone; mean ± SEM; * p<0.05). 
 
 
Figure 25: Cell population dynamics in WT and TLR4
-/-
 graft recipients 
BC implanted WT mice had more osteoblast and macrophage infiltration versus TLR4
-/-
mice. (A-B) Following 
pentachrome staining, cuboidal OBs and osteocytes were observed on the endocortical side of the calvarial bone in 
WT group, whereas fewer OBs with a flatter morphology were observed in the TLR4
-/-
 group in presence of 
morselized bone components. Larger areas of mineralized woven bone were evident in WT compared to TLR4
-/-
 
group. (C) Immunohistochemical staining revealed more intense F4/80 positive macrophage infiltration in the 
periosteum of BC WT mice compared to BC TLR4
-/-
 mice. (D) Intense OPN staining was evident in both WT and 
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TLR4
-/-
 mice after engraftment with morselized bone. (Scale bar: 50 µm; bolded arrow indicated defect margin; Ec: 
endocortical side; Ob: osteoblasts; Wo: woven bone; mean ± SEM; *p<0.05). 
 
To detect osteoblast and macrophage lineage cell infiltration, pentachrome staining, OPN 
and F4/80 immunohistochemistry staining were performed on day 7 slides in BC WT and BC 
TLR4
-/-
 mouse groups. On day 7, more bone surface lining mononucleated osteoblasts and 
woven bone were evident in BC WT group than in BC TLR4
-/-
 group (Fig. 25A). These 
observations were consistent with the osteoblast count based on pentachrome staining analysis 
(Fig. 25A, 25B). Positive F4/80 macrophage lineage cells were observed in the BC WT group, 
especially in the regenerated periosteal region, whereas no obvious F4/80 positive cells were 
evident in the BC TLR4
-/- 
group on day 7 (Fig.25C). Intense OPN staining was observed in both 
the BC implanted WT and TLR4
-/-
 groups (Fig.25D).  
On day 28, remodeled woven bone matrix and thickened periosteum were observed in all 
three experimental groups. In addition, Howship’s lacunae at the edge of the graft implants and 
bony union of grafts and recipients were observed in WT group. In contrast, fibrous 
encapsulation of morselized bone components was observed in TLR4
-/-
 graft recipients 
(Fig.26A). Histomorphometric measurements of newly regenerated bone area indicated no 
significant difference among the three groups (Fig.26B; BC WT group: 0.14±0.01mm
2
; BC 
TLR4
-/-
 group: 0.19±0.04 mm
2
; BC+TLR4 inhibitor WT group: 0.15±0.02mm
2
). More intense 
OPN staining showing evidence of bone resorption near scalloped edges of the BC grafts (Fig. 
27A) and significantly more intense cathepsin K stained osteoclasts were observed in the WT 
group than in the TLR4
-/-
 group (Fig.27B and 27C).  
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Figure 26: Histology and histomorphometric analysis of calvarial bone repair in WT and TLR4
-/-
 graft 
recipients at post-operative day 28 
(A) Representative H&E stained images of the BC implanted WT, BC implanted TLR4
-/-
 mice and “BC+TLR4 
inhibitor” implanted WT groups. Newly-formed woven bone on the outer periphery of the BC implant (*) and 
Howship’s lacunae (arrow heads) were observed in WT mice, suggesting the presence of active remodeling. In 
TLR4
-/-
 mice, fibrous encapsulation of morselized BC (arrow) was observed with little-to-no signs of remodeling. 
(B) Histomorphometric analysis revealed similar area of regenerated bone among the three groups on day 28. (Scale 
bar: 50 m; bolded arrow indicated defect margin; * indicated newly-regenerated bone on the surface of grafts; BC: 
morselized bone component implants; Wo: woven bone; B.Ar: bone area; mean ± SEM). 
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Figure 27: Representative images showing OPN and cathepsin K stained slides of BC implanted WT and 
TLR4
-/-
 mice on day 28 
More intense OPN staining (A) showing evidence of bone resorption near scalloped edges of the grafts, and more 
intense cathepsin K staining (B) indicating more osteoclast infiltration was observed in WT mice compared to 
TLR4
-/-
 mice. (C) Histomorphometric analysis revealed significantly more cathepsin K stained osteoclast infiltration 
in WT mice than TLR4
-/- 
mice.  (Scale bar: 50 µm; mean ± SEM; *p<0.05) 
5.3.4 The Matrix-enriched Fraction of Morselized Bone Enhanced Calvarial Healing in 
WT Mice, not in TLR4
-/-
 Mice 
In order to determine the impact of bone graft component on calvarial repair, cell-enriched (CE) 
and matrix-enriched (ME) bone fractions were implanted in the calvarial defects in WT mice. On 
day 28, an overall more intense reaction of periosteum was shown in the ME group compared to 
the CE group. Remodeling bone matrix was evident in the soft tissue covering the defect in the 
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ME group (Fig. 28A). To determine if TLR4 signaling plays a role in matrix-induced calvarial 
defect healing, the CE and ME implants were similarly placed in calvarial defects in TLR4
-/-
 
mice. Histological characterization revealed that CE and ME implant groups presented a similar 
healing pattern in TLR4
-/-
 mice on postoperative day28. The majority of woven bone formation 
was evident on the endocortical side of the calvarial bone and adjacent to the original defect in 
both groups in TLR4
-/-
 mice (Fig. 28B). 
Histomorphometric measurements showed significantly more newly-formed bone in the 
ME group (0.18±0.01mm
2
) compared to CE (0.13±0.02mm
2
, p<0.05) and vehicle control 
(0.12±0.00mm
2
, p<0.05, data no shown) groups in WT mice on postoperative day28. No 
significant difference was shown between CE (0.18±0.00mm
2
) and ME (0.17±0.04 mm
2
) groups 
in TLR4
-/-
 mice on day28 (Fig. 28C). Calculation of newly-formed bone area based on 
radiographic images (Data not shown) on postoperative day28 revealed significantly more new 
bone formation in the ME group (1.70±0.13mm
2
; 66.79% healing) than in the CE group 
(1.01±0.11mm
2
, 39.91% healing, p<0.05) and the vehicle control group (0.65±0.12mm
2
, 25.59% 
healing, p<0.001, data not shown) in WT mice. CE and ME implanted TLR4
-/-
 mice exhibit 
comparable bone healing (CE: 0.90±0.14mm
2
; 35.43% healing; ME: 1.05±0.16mm
2
, 41.34% 
healing; Fig.28D).  
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Figure 28: Histology and histomorphometric analysis of WT and TLR4
-/-
 mice engrafted with fractionated 
bone components at day 28 
Representative images showing H&E stained slides of CE and ME implanted WT (A) and TLR4
-/-
 (B) mice on day 
28. Notice: larger area of new bone at the endocortical side in ME implanted WT mice than CE group, and a similar 
healing pattern after ME and CE were implanted in TLR4
-/-
 mice. On day 28, histomorphometric (C) and 
radiographic (D) analyses revealed more bone formation in the ME group than the CE group in WT mice. No 
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significant differences in bone formation were observed between CE and ME implanted TLR4
-/-
 mice. (Scale bar: 50 
µm; CE: cell-enriched implant; ME: matrix-enriched implant; arrow indicated defect margin; Ec: endocortical side; 
Wo: woven bone; Lm: lamellar bone; B.Ar: bone area; mean ± SEM; * p<0.05). 
5.4 DISCUSSION 
Although various engineered materials including ceramics and metal implants have been 
developed for bone repair, autologous and allogeneic bone implants remain the graft materials of 
choice for bone reconstruction. The successful integration of implant material with the host 
requires the implanted bone graft to undergo remodeling and the induction of the healing 
cascade. The TLR receptors play a unique role in tissue repair by helping to regulate the innate 
inflammatory response to damage. Here, our data highlight a critical role for TLR4 signaling in 
graft-mediated calvarial repair. 
The impact of inflammation on healing is complex and may be either beneficial or 
detrimental to repair 
202,203
.
  
Recent advances in our understanding of the innate immune response 
have helped to distinguish between tissue-protective and tissue-destructive inflammatory 
signaling pathways 
90
. In a previous study,
 
accelerated bone healing within a calvarial defect 
model was observed in TLR4
-/-
 mice, suggesting that TLR4 signaling is detrimental to the 
normal  healing of calvarial bone defects
  78 
. In contrast to our previous findings, we report here 
that TLR4 is required to support graft-induced bone repair using a calvarial defect model. At 
day 7 after implantation, WT mice showed more F4/80 positive macrophage lineage cell 
infiltration, while macrophages were not detected in TLR4
-/-
 mice after bone component 
implantation. Inflammation promotes cell proliferation and migration into the fracture site to 
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trigger the repair and healing response within damaged bone 
76,90
. In addition, we showed that 
surgical implantation of morselized bone into damaged soft tissue induced a deleterious, TLR4-
dependent, systemic inflammatory response 
104
.
 
Together, these data suggest that TLR4 functions 
differently in our two models of craniofacial bone injury and repair. Specifically, TLR4 function 
delays normal bone healing, but is essential for graft-induced bone formation. The results we 
present here suggest that certain molecular signals within bone graft require TLR4 signaling to 
induce bone healing. Whether allograft or synthetic graft material-assisted healing also need 
TLR4 signaling, or manipulating TLR4-induced inflammatory response will assist in allograft or 
biomaterials-mediated bone healing requires better investigation.  
BC grafts were obtained from different mice of the same strain (WT, C57BL-6J). Thus, 
grafts were considered to be allogeneic in source 
204-207
. Allogeneic bone is frequently employed 
as a decellularized graft material, but is generally inferior to autologous bone graft and exhibits 
inferior remodeling upon implantation. Coating of structural allografts with RANKL and VEGF 
resulted in marked remodeling, improved vascularization, and enhanced bone repair, however, 
suggesting an essential role for remodeling in forming bony unions between grafts and host bone 
tissue 
208
. Our results support and extend this finding by suggesting that modulator of the innate 
immune response (TLR4) is required for graft remodeling and for subsequent bone healing. In 
our study, engraftment of WT mice with BC grafts resulted in earlier mineralization, more 
pronounced infiltration of regenerating tissue with osteoblasts, and more F4/80 stained 
macrophage infiltration relative to TLR4
-/-
 recipients at day 7 (Fig.2, 3). At day 28, implanted 
grafts in WT recipients showed irregular reversal lines and evidence of remodeling, whereas 
grafts in TLR4
-/-
 recipients showed relatively smooth margins and no obvious signs of 
remodeling (Fig.4 and Fig.5). Qualitative and quantitative µCT analyses revealed graft-enhanced 
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repair in WT mice, but not in TLR4
-/-
 mice. Moreover, inhibition of TLR4 suppressed healing in 
WT graft recipients, resulting in healing rates similar to those observed in TLR4
-/- 
graft recipients 
between days 7 and 14. Healing was accelerated in the inhibitor group at later time points, 
presumably due to a decline in the local concentration of the inhibitor and restoration of TLR4 
signaling over time. Because there was little or no evidence of graft remodeling (normally 
caused by osteoclastic destruction of the bone graft surface) in mice lacking the TLR4 gene, it is 
likely that TLR4 signaling is needed to induce graft remodeling.  
We also sought to determine which fraction of bone graft triggers TLR4-dependent bone 
healing. It has been argued that the regenerative potential of bone graft is dependent upon the 
efficient transfer of progenitor cells to the defect site 
191,192
, although donor cells typically fail to 
survive beyond hours to weeks 
193,194
.
 
In our previous work 
78
,
 
we used radiographic bone 
measurement to assess bone repair in a calvarial defect model and observed that 33.14% of the 
defect had regenerated by day 28 in WT mice, while the current study showed that BC and ME 
(matrix-enriched) groups achieved 74.80% and 66.79%, respectively (Fig.6). The CE (cell-
enriched) implant, in contrast, failed to stimulate bone repair beyond control values. 
Furthermore, comparable levels of healing were observed in both ME- and CE- engrafted TLR4
-
/-
 mice (Fig.6). These combined observations suggest that the matrix-bearing fraction of 
morselized bone bears primary responsibility for graft-induced bone regeneration and this bone 
healing effect is also partially TLR4 dependent. Disparities between our findings and those 
reported in other studies 
209,210
 may be due to the differences in graft fractionation procedures.  
Several points of considerations should be noted in this study including our use of a 
larger graft and approach for measuring bone formation. Firstly, the graft size was designed to be 
larger than the defect size to facilitate stable placement of grafts on the top of the calvarial defect 
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site, thereby ensuring consistency among all recipient mice. Secondly, we employ separate 
approaches for measuring bone formation (μCT and histolomorphometric analyses).  In our μCT 
analysis, we measured all mineralized tissue within the ROI, thus including both regenerated 
host new bone and remodeled bone graft. However, in our histomorphometric analysis, only 
newly-regenerated host bone was measured as some bone grafts remained as tiny pieces which 
made it challenging to accurately measure remodeled bone grafts (suppl Fig.2). As a result, a 
slight discrepancy exists between our μCT and histomorphometric analysis (Fig.1B and Fig. 6C). 
This discrepancy also explains the lack of significant differences among “BC WT”, “BC TLR4-/-
”, and “BC+TLR4 inhibitor WT” groups in histomorphometric measurements (Fig.4). However, 
this slight discrepancy in measurement does not alter the key finding of the study.  
In summary for this chapter, our results suggest that the healing effect of bone graft was 
inhibited without TLR4 signaling using a TLR4
 
gene knockout mouse model or the local 
delivery of TLR4 peptide inhibitor. These observations together establish an important and novel 
role of TLR4 in the healing effect driven by bone graft, especially the matrix-enriched fraction. 
Future work will seek to identify the molecular signals released from bone graft or the ECM 
component that is recognized by TLR4 and capable of inducing bone remodeling and bone 
formation. 
In my study, I aimed to understand the role of TLR4-associated pathway mediators in 
calvarial bone healing in the absence and presence of allograft implantation. In the 2
nd
 , 3
rd
 and 
4
th
 chapters, the results showed that dendritic cell expression of TLR4-mediated MyD88 
signaling was detrimental for calvarial bone healing. In addition, TLR4 depletion in myeloid 
cells also resulted in accelerated bone healing via enhanced osteoclastogenesis within a non-
compromised calvarial defect model. While in the 5
th
 chapter, lacking TLR4 signal after allograft 
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implantation leaded to decreased osteoclast-mediated graft remodeling and subsequential 
inhibited bone healing, establishing an important and novel role of TLR4 in graft-mediated bone 
repair. Taken together, my study suggests that TLR4 might have a regulatory role in skeletal 
homeostasis, due to its regulating of osteoclastogenesis. As such, in the future, appropriate 
modulation of TLR4 signaling can be used to initiate early healing after fracture or adding TLR4 
signaling for graft-mediated therapy to improve clinical outcomes. 
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